title,title_link,authors,publications,snippet,hcp_name,num_articles
[HTML][HTML] Cardiovascular toxicity caused by cancer treatment: strategies for early detection,https://www.sciencedirect.com/science/article/pii/S1470204509700427,"R Altena, PJ Perik, DJ Van Veldhuisen, EGE De Vries… ","The lancet oncology, 2009 ","Cardiovascular toxicity is one of the most devastating complications of cancer treatment and 
can arise during or shortly after treatment, or even several years later. Identification of the left 
ventricular ejection fraction (LVEF) is the most common method to screen for toxic effects on …",Renske Altena,10
"[HTML][HTML] Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and …",https://www.sciencedirect.com/science/article/pii/S0923753419371935,"J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer… ","Annals of oncology, 2013 ","In November 2011, the Third European Consensus Conference on Diagnosis and Treatment 
of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed 
similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll …",Renske Altena,10
Angiotensin II–receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: A randomized clinical trial,https://jamanetwork.com/journals/jamaoncology/article-abstract/2529696,"AH Boekhout, JA Gietema, BM Kerklaan… ","JAMA …, 2016 ","Importance This is the first randomized placebo-controlled evaluation of a medical intervention 
for the prevention of trastuzumab-related cardiotoxic effects. Objective To determine as 
the primary end point whether angiotensin II antagonist treatment with candesartan can …",Renske Altena,10
[HTML][HTML] Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring,https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3912982/,"R Altena, E van Roon, R Folkeringa, H de Wit… ","…, 2014 ","Figure 1. Median (5th and 95th percentiles) plasma levels of rivaroxaban after oral intake of 
20 mg, in patients with normal body mass index and normal renal function. Asterix indicates 
the plasma rivaroxaban concentration in our patient, which was measured from a blood …",Renske Altena,10
[HTML][HTML] Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin-and cisplatin-based treatment of testicular cancer patients and relate to …,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115372,"R Altena, RSN Fehrmann, H Boer, EGE de Vries… ","PloS one, 2015 ","Introduction Chemotherapy-related endothelial damage contributes to the early development 
of cardiovascular morbidity in testicular cancer patients. We aimed to identify relevant 
mechanisms of and search for candidate biomarkers for this endothelial damage. Methods …",Renske Altena,10
Sickness absence and disability pension among swedish women prior to breast cancer relapse with a special focus on the roles of treatment and comorbidity,https://onlinelibrary.wiley.com/doi/abs/10.1111/ecc.13353,"SAM Gernaat, A Johnsson, R Altena… ","European Journal of …, 2021 ","Objective We aimed to determine the longitudinal prevalence and the predictors of sickness 
absence (SA) and disability pension (DP) in breast cancer (BC) women who eventually 
developed relapse. Methods A total of 1293 BC women, who were ages 20–63 years, diagnosed …",Renske Altena,10
Long-term favorable effects of physical exercise on burdensome symptoms in the optitrain breast cancer randomized controlled trial,https://journals.sagepub.com/doi/abs/10.1177/1534735420905003,"F Wiggenraad, KA Bolam, S Mijwel… ","Integrative cancer …, 2020 ","Purpose: We evaluate longitudinal changes in symptom clusters and core burdensome 
symptoms in breast cancer patients who participated in the OptiTrain trial. Methods: 240 women 
were randomized to 16 weeks of supervised exercise (RT-HIIT or AT-HIIT) or usual care (UC) …",Renske Altena,10
"[HTML][HTML] Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, molecular, and clinical work-up of a rare case",https://link.springer.com/article/10.1007/s12022-020-09606-5,"A Stenman, LS Hellgren, K Jatta, M Hysek… ","Endocrine …, 2020 ","Anaplastic thyroid carcinoma (ATC) exhibits an exceedingly poor prognosis, and the current 
treatment options are, for most cases, palliative by nature. Few reports of long-time survivors 
exist, although in these patients, tumors often were limited to the thyroid and/or regional …",Renske Altena,10
[HTML][HTML] Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy …,https://www.sciencedirect.com/science/article/pii/S0959804915010394,"H Boer, NDL Westerink, R Altena, J Nuver… ","European Journal of …, 2016 ","Purpose Chemotherapy-treated testicular cancer survivors are at risk for development of the 
metabolic syndrome, especially in case of decreased androgen levels. Polymorphisms in 
the gene encoding steroid 5-α-reductase type II (SRD5A2) are involved in altered androgen …",Renske Altena,10
[HTML][HTML] Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer,https://cardiooncologyjournal.biomedcentral.com/articles/10.1186/s40959-021-00105-y,"R Altena, L Hubbert, NA Kiani… ","Cardio …, 2021 ","Cancer treatment-related morbidity relevantly compromises health status in cancer survivors, 
and efforts to optimise health-related outcomes in this population are vital to maximising 
healthy survivorship. A pre-treatment assessment – and possibly preventive management …",Renske Altena,10
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study,https://academic.oup.com/ehjqcco/article-abstract/6/2/147/5536718,"E Hedayati, A Papakonstantinou… ","… Journal-Quality of …, 2020 ","Aims Heart failure (HF) patients diagnosed with breast cancer (BC) may have a higher risk 
of death, and different HF presentation and treatment than patients without BC. Methods and 
results A total of 14 998 women with incident HF (iHF) or prevalent HF (pHF) enrolled in the …",Renske Altena,20
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study,https://academic.oup.com/ehjqcco/article-abstract/6/2/147/5536718,"E Hedayati, A Papakonstantinou… ","… Journal-Quality of …, 2020 ","Aims Heart failure (HF) patients diagnosed with breast cancer (BC) may have a higher risk 
of death, and different HF presentation and treatment than patients without BC. Methods and 
results A total of 14 998 women with incident HF (iHF) or prevalent HF (pHF) enrolled in the …",Renske Altena,20
[HTML][HTML] Heart matters: cardiovascular complications related to cancer treatment,https://www.futuremedicine.com/doi/full/10.2217/fon.12.194,"R Altena, DJ Van Veldhuisen ","Future Oncology, 2013 ","Panel enforced the need for the development of evidence-based monitoring strategies for 
cardiotoxicity during and after cancer treatments [6]. Up to now, no studies have been performed 
that investigate the most effective schedule of timing and contents of cardiac follow-up. …",Renske Altena,20
[PDF][PDF] Use of Sickness Benefits by Patients With Metastatic Breast Cancer–A Swedish Cohort Study,https://www.researchsquare.com/article/rs-605050/latest.pdf,"R Altena, SAM Gernaat, U Wilking, NA Kiani… ",2021 ,"Background Advances in the treatment of metastatic breast cancer (mBC) have led to 
improved life expectancy. Many cancer survivors desire to return to paid work to enhance their 
sense of well-being. For patients with mBC, little is known about how the diagnosis impacts …",Renske Altena,20
Sickness absence and disability pension among Swedish women before breast cancer relapse.,https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e14121,"H Elham, S Gernaat, A Johnsson, U Wilking, R Altena ",2020 ,"e14121 Background: Sickness absence (SA) and disability pension (DP) from diagnosis of 
primary breast cancer (BC) among patients who in a later stage will develop a recurrence or 
metastatic disease is unknown. This study explores the prevalence and risk factors of SA and …",Renske Altena,20
Macrophage inhibitory cytokine 1 plasma levels in testicular cancer patients during cisplatin combination treatment and their relation to endothelial damage.,https://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.e15035,"R Altena, RSN Fehrmann, H Boer, EGE de Vries… ",2012 ,"e15035 Background: Chemotherapy- (CTx) related endothelial damage contributes to 
cardiovascular morbidity in testicular cancer (TC) patients (pts). We used an unbiased translational 
approach to identify mechanisms of and potential biomarkers for this damage. Methods: …",Renske Altena,20
Bleomycin-induced pulmonary changes on restaging CT scans: Frequency and correlation with fibrosis markers.,https://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.4540,"NDL Westerink, S Lubberts, MW den Hollander… ",2015 ,"4540 Background: Bleomycin-induced pneumonitis (BIP) is a well-known, potentially fatal, 
side-effect in metastatic testicular cancer (mTC). We prospectively investigated I: prevalence 
of lesions suspect for bleomycin-induced pulmonary changes on restaging CT scans; II: …",Renske Altena,20
High risk vascular fingerprint in patients treated with cisplatin-based chemotherapy for testicular cancer.,https://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e15556,"S Lubberts, H Boer, R Altena, C Meijer, AM van Roon… ",2015 ,"e15556 Background: Metastatic TC (mTC) can be cured with cisplatin-based chemotherapy 
(CT). This comes at the price of increased risk for premature cardiovascular disease (CVD). 
We investigated risk factors (RFs) and markers of early vascular damage. Methods: …",Renske Altena,20
Association of long-term exposure to circulating platinum with adverse late effects in testicular cancer survivors.,https://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.4528,"H Boer, JH Proost, J Nuver, S Bunskoek, JQ Gietema… ",2012 ,"4528 Background: Successful platinum(Pt)-based chemotherapy for testicular cancer (TC) 
comes at the price of late cardiovascular morbidity and neurotoxicity. Damage induced by 
circulating Pt could be an etiological mechanism. We investigated the relation between …",Renske Altena,20
[HTML][HTML] High intensity exercise during breast cancer chemotherapy-effects on long-term myocardial damage and physical capacity-data from the OptiTrain RCT,https://link.springer.com/article/10.1186/s40959-021-00091-1,"J Ansund, S Mijwel, KA Bolam, R Altena, Y Wengström… ","Cardio-oncology, 2021 ","Adjuvant systemic breast cancer treatment improves disease specific outcomes, but also 
presents with cardiac toxicity. In this post-hoc exploratory analysis of the OptiTrain trial, the 
effects of exercise on cardiotoxicity were monitored by assessing fitness and biomarkers over the …",Renske Altena,20
[CITATION][C] Chemotherapy-related cardiovascular morbidity in testicular cancer patients: markers & mechanisms,https://research.rug.nl/en/publications/chemotherapy-related-cardiovascular-morbidity-in-testicular-cance,R Altena ,2011 ,… Renske Altena …,Renske Altena,30
[CITATION][C] Chemotherapy-related cardiovascular morbidity in testicular cancer patients: markers & mechanisms,https://research.rug.nl/en/publications/chemotherapy-related-cardiovascular-morbidity-in-testicular-cance,R Altena ,2011 ,… Renske Altena …,Renske Altena,30
[CITATION][C] The editors extend their gratitude and appreciation to the following reviewers whose com-ments and criticism ensure the quality of the articles published in …,https://www.karger.com/Article/Abstract/521123,"S Alipour, R Altena, B Ataseven, W Bader, M Balic ","Breast Care, 2021 ","… Carl Ade, Manhattan, KS, USA Felipe Ades, Sao Paulo, Brazil Elena Akimova, Vienna, 
Austria Sadaf Alipour, Tehran, Iran Renske Altena, Solna, Sweden Beyhan Ataseven, Essen, 
Germany Eli Avisar, Miami, FL, USA Werner Bader, Bielefeld, Germany Marija Balic, Graz …",Renske Altena,30
Cardiovascular risk in long‐term survivors of testicular cancer,https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.23389,"DJ Vaughn, SC Palmer, JR Carver, LA Jacobs… ","Cancer, 2008 ","BACKGROUND Long‐term survivors of testicular cancer (TC) who received cisplatin‐based 
chemotherapy have an increased risk of cardiovascular disease. A cross‐sectional study 
was performed to objectively assess cardiovascular risk, subclinical atherosclerosis, and …",Renske Altena,30
Cardiac protection in HER2-targeted treatment: how should we measure new strategies?,https://jamanetwork.com/journals/jamaoncology/article-abstract/2529692,"A Barac, SM Swain ","JAMA oncology, 2016 ","Therapies targeted at human endothelial growth factor receptor 2 (HER2) have revolutionized 
the treatment of HER2-positive breast cancer and continue to improve survival of patients 
with early and metastatic breast cancer. Cardiac dysfunction, either as asymptomatic decline …",Renske Altena,30
Cardiac protection in HER2-targeted treatment: how should we measure new strategies?,https://jamanetwork.com/journals/jamaoncology/article-abstract/2529692,"A Barac, SM Swain ","JAMA oncology, 2016 ","Therapies targeted at human endothelial growth factor receptor 2 (HER2) have revolutionized 
the treatment of HER2-positive breast cancer and continue to improve survival of patients 
with early and metastatic breast cancer. Cardiac dysfunction, either as asymptomatic decline …",Renske Altena,30
Potential Benefit of Low-Dose Candesartan in Trastuzumab-Induced Cardiotoxic Effects,https://jamanetwork.com/journals/jamaoncology/article-abstract/2575464,"S Yun, R Khoubyari, I Abraham ","JAMA oncology, 2017 ","To the Editor From their trial comparing high-dose candesartan vs placebo in patients with 
early-stage breast cancer, Boekhout et al1 concluded that candesartan does not have a 
clinically significant benefit for preventing trastuzumabinduced cardiotoxic effects. This trial …",Renske Altena,30
[BOOK][B] Costs and effects of laparoscopy versus laparotomy in women with early endometrial cancer,https://research.rug.nl/files/14663943/Complete%20thesis,CBM Bijen ,2010 ,"Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute 
the text or part of it without the consent of the author (s) and/or copyright holder (s), unless 
the work is under an open content license (like Creative Commons). …",Renske Altena,30
[CITATION][C] The editors extend their gratitude and appreciation to the following reviewers whose com-ments and criticism ensure the quality of the articles published in …,https://www.karger.com/Article/Abstract/512448,"M Banaszynski, KH Breuing, MA Dalzell ","Breast Care, 2020 ","Acknowledgement to Reviewers Page 1 Acknowledgement to Reviewers The editors extend 
their gratitude and appreciation to the following reviewers whose comments and criticism 
ensure the quality of the articles published in this journal. Stefan Aebi, Lucerne Elena Akimova…",Renske Altena,30
Динаміка гемодинамічних та гематологічних показників при ургентних оперативних втручаннях,https://odmu.edu.ua/xmlui/handle/123456789/8161,"РС Вастьянов, ІВ Савицький, ОФ Дзигал, СВ Руснак… ",2020 ,"Актуальною для забезпечення хірургічної допомоги залишається проблема кровотеч на 
різних етапах лікування. Різними авторами наводяться численні методи діагностики, в 
основі яких лежать гемодинамічні і гематологічні патогенетичні зміни в організмі. Нами …",Renske Altena,30
"Correlation between low-dose chest computed tomography and RT-PCR results for the diagnosis of COVID-19: A report of 27,824 cases in tehran, Iran",https://www.sciencedirect.com/science/article/pii/S1076633220305420,"A Zali, MR Sohrabi, A Mahdavi, N Khalili, MS Taheri… ","Academic …, 2021 ","Rationale and Objectives Real-time polymerase chain reaction (RT-PCR) remains the gold 
standard for confirmation of Coronavirus Disease 2019 (COVID-19) despite having many 
disadvantages. Here, we investigated the diagnostic performance of chest computed …",Reza Khoshnoud,10
"Genes related to growth regulation, DNA repair and apoptosis in an oestrogen receptor-negative (MDA-231) versus an oestrogen receptor-positive (MCF-7) breast …",https://www.karger.com/Article/Abstract/77722,"S Skog, Q He, R Khoshnoud, T Fornander, LE Rutqvist ","Tumor Biology, 2004 ","The molecular mechanism(s) behind the development of endocrine resistance in breast 
cancer remains controversial. Here, we compare the capability of oestrogen receptor (ER)-negative 
cells (MDA-231) versus ER-positive tamoxifen-sensitive cells (MCF-7) to handle DNA …",Reza Khoshnoud,10
Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures,https://www.spandidos-publications.com/ijmm/16/6/979,"H Von Euler, R Khoshnoud, Q He… ","International …, 2005 ","Heterogeneous gene expression in tumours and the degradation of RNA when sampling under 
non-RNAse-free conditions may limit the potential benefit of cDNA array studies. This study 
examines changes in the integrity of RNA by means of RNA gel electrophoresis at various …",Reza Khoshnoud,10
Experimental investigation on self-compacting concrete reinforced with steel fibers,https://www.dbpia.co.kr/Journal/articleDetail?nodeId=NODE10235262,"O Zarrin, HR Khoshnoud ","Structural engineering and mechanics: An …, 2016 ","Self-Compacting Concrete (SCC) has been originally developed in Japan to offset a growing 
shortage of skilled labors, is a highly workable concrete, which is not needed to any vibration 
or impact during casting. The utilizing of fibers in SCC improves the mechanical properties …",Reza Khoshnoud,10
[HTML][HTML] Experimental study of masonry infill reinforced concrete frames with and without corner openings,https://www.koreascience.or.kr/journal/view.jsp?kj=KJKHB9&py=2016&vnc=v57n4&sp=641,"HR Khoshnoud, K Marsono ","Structural Engineering and …, 2016 ","Reinforced concrete frame buildings with masonry infill walls are one of the most popular 
structural systems in the world. In most cases, the effects of masonry infill walls are not considered 
in structural models. The results of earthquakes show that infill walls have a significant …",Reza Khoshnoud,10
Surgical management of the fourth ventricular tumors using telovelar approach and the role of neuroendoscopy: Post-operative outcome and long-term results in a …,https://www.sciencedirect.com/science/article/pii/S0303846720307629,"EN Maloumeh, RJ Khoshnoud, K Ebrahimzadeh… ","Clinical Neurology and …, 2021 ","Objectives The telovelar approach is a surgical method performed through natural corridors 
of the brain to access the fourth ventricle. The aim of this study is to assess the results of this 
approach as well as the role of neuroendoscopy in surgical management of fourth ventricle …",Reza Khoshnoud,10
[PDF][PDF] Effectiveness of Extremely Low Frequency Electromagnetic Field and Pulsed Low Level Laser Therapy in Acute Stroke Treatment,https://www.sid.ir/FileServer/JE/GHA50004620200304,"F Ashrafi, A Rezaei, A Azhideh, F Tabeie… ","International Clinical …, 2020 ","Introduction: Stroke is one of the most devastating neurologic conditions in the world. Despite 
all the efforts that have been made for effective treatment, the prevalence of this medical 
condition is still high. One of the new methods in the treatment of patients is the use of low …",Reza Khoshnoud,10
[PDF][PDF] Transverse myelitis in COVID-19 patients: Report of two cases,https://www.researchsquare.com/article/rs-107744/latest.pdf,"S Advani, A Zali, D Ommi, A Fatemi, RJ Khoshnoud… ",2020 ,"Background: COVID-19 has been associated with several neurological complications. One of 
these complications is transverse myelitis. Several cases of acute transverse myelitis are 
reported in association with this disease among the world. As there is lack of knowledge about …",Reza Khoshnoud,10
Fatal cases of strychnine ingestion referred to Fars Legal Medicine Organization; Autopsy findings and Analytical methods used in strychnine detection,http://tips.sums.ac.ir/index.php/TiPS/article/view/130,"M Hosseini, A Malekpour, R Khoshnoud… ","Trends in …, 2017 ","Strychnine is a toxic alkaloid which might be the source of poisoning with homicidal and 
suicidal purposes. Eleven fatal cases of strychnine ingestion were considered in this study. 
Strychnine was isolated from biological samples using the solid phase extraction (SPE) …",Reza Khoshnoud,10
Saccular mycotic aneurysm of descending thoracic aorta secondary to vertebral hydatid disease: A rare case,https://journals.sagepub.com/doi/abs/10.1177/1708538121994370,"M Mozafar, H Haghighatkhah, RJ Khoshnoud… ","…, 2021 ","Background/Objective Hydatid disease of the aorta is very rare. Hydatid disease can result in 
saccular aneurysm of the thoracic and abdominal aorta. Case report We report a rare case 
of saccular aneurysm of the distal descending thoracic aorta. The diameter of the aneurysm …",Reza Khoshnoud,10
The Sensorineural Hearing Loss Related to a Rare Infratentorial Developmental Venous Angioma: A Case Report and Review of Literature,https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0041-1725960,"K Ebrahimzadeh, HH Tavassol… ","… Surgery Part A …, 2021 ","Background Developmental venous anomaly (DVA) is a benign venous abnormality draining 
normal brain parenchyma. It is mostly asymptomatic; however, rare complications such 
as hemorrhage may lead to symptomatic conditions. Headache and seizure are the most …",Reza Khoshnoud,20
[PDF][PDF] Assessment of FEMA 356 nonlinear static procedure and modal pushover analysis for seismic evaluation of buildings,http://www.samt2000.com/uploads/397624technopress.pdf,"HR Khoshnoud, K Marsono ","Structural Engineering and Mechanics, 2012 ","Nonlinear static analysis as an essential part of performance based design is now widely used 
especially at design offices because of its simplicity and ability to predict seismic demands 
on inelastic response of buildings. Since the accuracy of nonlinear static procedures (NSP) …",Reza Khoshnoud,20
The impact of RNA standardization and heterogeneous gene expression on the results of cDNA array of human breast carcinoma,https://www.spandidos-publications.com/10.3892/ijmm_00000399,"R Khoshnoud, Q He, M Sylván… ","International …, 2010 ","cDNA microarray is an established technique. However, difficulties such as handling tissue 
samples under RNase-free conditions, the heterogeneous tumor composition, ie non-malignant 
versus malignant cells and different pathologic types of malignant cells, and lack of …",Reza Khoshnoud,20
[PDF][PDF] Altered Transcript Levels of Cytokines in COVID-19 Patients,https://www.researchsquare.com/article/rs-126215/latest.pdf,"M Samsami, A Fatemi, RJ Khoshnoud, K Kohansal… ",2020 ,"The pandemic caused by severe acute respiratory syndrome coronavirus 2 and the related 
disorder ie “coronavirus disease 2019”(COVID-19) have encouraged researchers to unravel 
the molecular mechanism of disease severity. Several lines of evidence support the impact of…",Reza Khoshnoud,20
Glioblastoma simultaneously present with adjacent meningioma: Case report,https://journals.sbmu.ac.ir/Neuroscience/article/view/13193,"MR Shahmohammadi, H Javadian… ","International Clinical …, 2016 ","In this article, we report a 49-year-old woman with simultaneous meningioma and astrocytoma 
occurrence in the same patients without radiotherapy, phacomatosis, or any genetic 
disorders. We aimed to define surgical management and the etiopathogenic correlations of …",Reza Khoshnoud,20
Cervical Spine Epidural Abscess Caused by Brucellosis: A Case Report and Literature Review,https://europepmc.org/article/ppr/ppr411719,"M Shafizad, S Ehteshami, H Shojaei, RJ Khoshnoud ",2021 ,"We report a rare case of cervical epidural abscess at the C5-C6 levels. The patient underwent 
surgery with complete abscess removal through C6 vertebral body corpectomy. The result 
of bacteriological culture was Brucella melitensis. Brucellosis must be considered as a …",Reza Khoshnoud,20
[PDF][PDF] In vitro assessment of synthetic nano engineered graft designed for further clinical study in nerve regeneration,https://www.sid.ir/FileServer/JE/50004620180305,"A Sadeghi, F Moztarzadeh, JA Mohandesi… ","International Clinical …, 2018 ","Background: Electrospun nanofibrous scaffolds are considered as promising candidates in 
neural tissue regeneration due to their ability to support neural cell attachment, spreading 
and proliferation. Methods: In this paper, various type of nanofibers scaffold based on …",Reza Khoshnoud,20
[PDF][PDF] MODIFIED SOLID PHASE EXTRACTION OF ORGANOPHOSPHORUS PESTICIDES; REPORT OF TWO CASES OF SUICIDES,http://ijpbs.com/ijpbsadmin/upload/ijpbs_57b9bda063d05.pdf,"M Hosseini, H Abbasinia, A Malekpour, T Tarian… ",ijpbs.com,"Acute pesticide toxicity is extremely common in developing countries of the Asia–Pacific region, 
particularly in individuals with low education and poor regulatory frameworks [1]. The excessive 
and unregulated use of pesticides in agriculture and public health has caused severe …",Reza Khoshnoud,20
A Case Report of Suicide with Chloroquine Overdose and Review of Literature,http://jabs.fums.ac.ir/article-1-980-en.html,"M Hosseini, R Khoshnoud, S Gholamzadeh… ","Journal of Fasa …, 2016 ","Background & Objective: Suicide is considered as the tenth cause of death worldwide. There 
are several suicide reports consist in the use of certain unusual drugs, such as chloroquine. 
Case report: The cadaver of a 25-year-old single woman was found dead in her home and …",Reza Khoshnoud,20
Experimental study to evaluate dynamic specifications of reinforced concrete moment resistant frame based on forced vibration test with structure-foundation-soil …,https://jcr.guilan.ac.ir/article_3749_en.html?lang=fa,"HR Khoshnoud, A Alireza Heydari Heydari ","Concrete Research, 2019 ","AbstractStructures dynamic characteristics including natural periods, mode shapes and damping 
ratios are the most important factors of the structure's response to earthquakes. Numerical 
models used to determine the dynamic characteristics of structures are usually based on …",Reza Khoshnoud,20
[BOOK][B] Adjuvant tamoxifen in breast cancer: clinical and preclinical studies on the prediction value of estrogen receptor,https://openarchive.ki.se/xmlui/handle/10616/38552,MR Khoshnoud ,2010 ,"Breast cancer (BC) exhibits great heterogeneity at histophatological, clinical and molecular 
levels. However, the different clinical outcomes in patients with seemingly similar breast cancer 
have led scientists to search for subgroups or for factors and characteristics related to the …",Reza Khoshnoud,30
[BOOK][B] Adjuvant tamoxifen in breast cancer: clinical and preclinical studies on the prediction value of estrogen receptor,https://openarchive.ki.se/xmlui/handle/10616/38552,MR Khoshnoud ,2010 ,"Breast cancer (BC) exhibits great heterogeneity at histophatological, clinical and molecular 
levels. However, the different clinical outcomes in patients with seemingly similar breast cancer 
have led scientists to search for subgroups or for factors and characteristics related to the …",Reza Khoshnoud,30
[BOOK][B] Adjuvant tamoxifen in breast cancer: clinical and preclinical studies on the prediction value of estrogen receptor,https://openarchive.ki.se/xmlui/handle/10616/38552,MR Khoshnoud ,2010 ,"Breast cancer (BC) exhibits great heterogeneity at histophatological, clinical and molecular 
levels. However, the different clinical outcomes in patients with seemingly similar breast cancer 
have led scientists to search for subgroups or for factors and characteristics related to the …",Reza Khoshnoud,30
[BOOK][B] Adjuvant tamoxifen in breast cancer: clinical and preclinical studies on the prediction value of estrogen receptor,https://openarchive.ki.se/xmlui/handle/10616/38552,MR Khoshnoud ,2010 ,"Breast cancer (BC) exhibits great heterogeneity at histophatological, clinical and molecular 
levels. However, the different clinical outcomes in patients with seemingly similar breast cancer 
have led scientists to search for subgroups or for factors and characteristics related to the …",Reza Khoshnoud,30
Assessment of Anterior Cervical Discectomy,https://journals.sbmu.ac.ir/neuroscience/article/view/6534,"A Zali, A Zarghi, AS Seddighi… ","International Clinical …, 2014 ","Abstract Background: The purpose of this study is to evaluate anterior cervical discectomy. 
Materials and Methods: This retrospective study was conducted on 43 patients underwent 
surgery through standard Smith-Robison Technique with fusion. Postoperative follow-up period …",Reza Khoshnoud,30
Assessment of Anterior Cervical Discectomy,https://journals.sbmu.ac.ir/neuroscience/article/view/6534,"A Zali, A Zarghi, AS Seddighi… ","International Clinical …, 2014 ","Abstract Background: The purpose of this study is to evaluate anterior cervical discectomy. 
Materials and Methods: This retrospective study was conducted on 43 patients underwent 
surgery through standard Smith-Robison Technique with fusion. Postoperative follow-up period …",Reza Khoshnoud,30
مطالعه تجربی تعیین مشخصات دینامیکی ساختمان پنج طبقه قاب خمشی بتنی با استفاده از آزمایش ارتعاش اجباری‎,https://jcr.guilan.ac.ir/mobile/article_3749.html?lang=fa,"خوشنود, حیدری ","تحقیقات بتن, 2019‎ ","خلاصه خواص دینامیکی سازه ها شامل پریود های طبیعی، مودهای ارتعاشی و نسبت میرایی مهمترین 
عواملی هستند که تعیین کننده عکس العمل های سازه در مقابل زلزله می باشند. مدل های نرم افزاری که 
جهت تعیین خصوصیات دینامیکی سازه مورد استفاده قرار می گیرند، معمولا دارای فرضیات ساده کننده …‎",Reza Khoshnoud,30
ÉTUDE PARAMÉTRIQUE EN STATIQUE NON-LINAIRE DU FACTEUR DE COMPORTEMENT POUR LES STRUCTURES MÉTALLIQUES DIMENSIONNÉES SELON …,https://search.proquest.com/openview/94d9d00d97a14918dec0b324b1bb6f44/1?pq-origsite=gscholar&cbl=276222,"A Chekired, A Abed ","Annales du Bâtiment et des Travaux …, 2015 ","Despite compliance with recommendations made by seismic codes many structures suffer 
major damage during a major earthquake. The behavior of a structure during a severe 
earthquake is not necessarily the one intended by the designer. The interaction between …",Reza Khoshnoud,30
[BOOK][B] Adjuvant tamoxifen and luteinizing hormone-releasing hormone agonists in premenopausal breast cancer: On long-term benefits and side effects in a …,https://openarchive.ki.se/xmlui/handle/10616/41188,Á Sverrisdóttir ,2012 ,"Adjuvant endocrine therapy improves breast cancer survival, unconditional of other treatment. 
In premenopausal breast cancer, tamoxifen for 5 years is the standard treatment, with or 
without the addition of ovarian ablative therapy. The optimal timing and duration of ovarian …",Reza Khoshnoud,30
[PDF][PDF] ADJUVANT TAMOXIFEN AND LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS IN PREMENOPAUSAL BREAST CANCER,https://core.ac.uk/download/pdf/70340328.pdf,Á Sverrisdóttir ,2012 ,"Adjuvant endocrine therapy improves breast cancer survival, unconditional of other treatment. 
In premenopausal breast cancer, tamoxifen for 5 years is the standard treatment, with or 
without the addition of ovarian ablative therapy. The optimal timing and duration of ovarian …",Reza Khoshnoud,30
[HTML][HTML] Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma,https://www.nejm.org/doi/full/10.1056/nejmoa1308345,"OL Chinot, W Wick, W Mason… ","… England Journal of …, 2014 ","Background Standard therapy for newly diagnosed glioblastoma is radiotherapy plus 
temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab to 
radiotherapy–temozolomide for the treatment of newly diagnosed glioblastoma. Methods We …",Roger Henriksson,10
[HTML][HTML] Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic …,https://www.sciencedirect.com/science/article/pii/S1470204512702656,"A Malmström, BH Grønberg, C Marosi, R Stupp… ","The lancet oncology, 2012 ","Background Most patients with glioblastoma are older than 60 years, but treatment guidelines 
are based on trials in patients aged only up to 70 years. We did a randomised trial to assess 
the optimum palliative treatment in patients aged 60 years and older with glioblastoma. …",Roger Henriksson,10
[HTML][HTML] Genome-wide association study identifies five susceptibility loci for glioma,https://www.nature.com/articles/ng.407,"S Shete, FJ Hosking, LB Robertson, SE Dobbins… ","Nature …, 2009 ","To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide 
association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 
controls, with validation in three additional independent series totaling 2,545 cases and 2,953 …",Roger Henriksson,10
[HTML][HTML] European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas,https://www.sciencedirect.com/science/article/pii/S1470204517301948,"M Weller, M Van Den Bent, JC Tonn, R Stupp… ","The lancet oncology, 2017 ","The European Association for Neuro-Oncology guideline provides recommendations for the 
clinical care of adult patients with astrocytic and oligodendroglial gliomas, including 
glioblastomas. The guideline is based on the 2016 WHO classification of tumours of the central …",Roger Henriksson,10
[HTML][HTML] EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma,https://www.sciencedirect.com/science/article/pii/S1470204514700117,"M Weller, M van den Bent, K Hopkins, JC Tonn… ","The lancet oncology, 2014 ","This guideline provides recommendations for diagnostic and therapeutic procedures for 
patients with malignant gliomas. We differentiate evidence-based standards from reasonable 
options or non-evidence-based measures that should no longer be considered. The …",Roger Henriksson,10
[HTML][HTML] Detectable clonal mosaicism and its relationship to aging and cancer,https://www.nature.com/articles/ng.2270,"KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang… ","Nature …, 2012 ","In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide 
association studies, we observed large chromosomal abnormalities in a subset of clones in 
DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either …",Roger Henriksson,10
[HTML][HTML] EANO guidelines for the diagnosis and treatment of meningiomas,https://www.sciencedirect.com/science/article/pii/S1470204516303217,"R Goldbrunner, G Minniti, M Preusser… ","The Lancet …, 2016 ","Although meningiomas are the most common intracranial tumours, the level of evidence to 
provide recommendations for the diagnosis and treatment of meningiomas is low compared 
with other tumours such as high-grade gliomas. The meningioma task force of the European …",Roger Henriksson,10
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with …,https://ascopubs.org/doi/abs/10.1200/jco.2011.38.1095,"J Bergh, PE Jönsson, EK Lidbrink… ","Journal of Clinical …, 2012 ","Purpose To compare the effect of therapy with anastrozole versus a combination of fulvestrant 
and anastrozole in women in first relapse of endocrine-responsive breast cancer. Patients 
and Methods Postmenopausal women, or premenopausal women receiving a gonadotropin-…",Roger Henriksson,10
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation,https://www.embopress.org/doi/abs/10.1038/sj.emboj.7600342,"G Gur, C Rubin, M Katz, I Amit, A Citri, J Nilsson… ","The EMBO …, 2004 ","Kekkon proteins negatively regulate the epidermal growth factor receptor (EGFR) during 
oogenesis in Drosophila. Their structural relative in mammals, LRIG1, is a transmembrane 
protein whose inactivation in rodents promotes skin hyperplasia, suggesting involvement in …",Roger Henriksson,10
Parotid gland function during and following radiotherapy of malignancies in the head and neck: A consecutive study of salivary flow and patient discomfort,https://www.sciencedirect.com/science/article/pii/S0959804905800760,"L Franzén, U Funegård, T Ericson… ","European Journal of …, 1992 ","Radiotherapy of tumours in the head and neck region usually involves the salivary glands in 
the treatment volume with ensuing dryness and discomfort. In the present study, a prospective 
evaluation of the same patients were performed before, during radiotherapy and 6, 12 and …",Roger Henriksson,10
"[PDF][PDF] Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after …",https://www.researchgate.net/profile/Kjell-Grankvist/publication/12580142_Correlation_of_Vascular_Endothelial_Growth_Factor_Content_With_Recurrences_Survival_and_First_Relapse_Site_in_Primary_Node-Positive_Breast_Carcinoma_After_Adjuvant_Treatment/links/0046351dace409398c000000/Correlation-of-Vascular-Endothelial-Growth-Factor-Content-With-Recurrences-Survival-and-First-Relapse-Site-in-Primary-Node-Positive-Breast-Carcinoma-After-Adjuvant-Treatment.pdf,"B Linderholm, K Grankvist, N Wilking… ","Journal of Clinical …, 2000 ","Purpose: To determine the predictive value of vascular endothelial growth factor (VEGF) for 
relapse-free survival (RFS) and overall survival (OS) in primary node-positive breast cancer 
(NPBC) after adjuvant endocrine treatment or adjuvant chemotherapy. Materials and Methods…",Roger Henriksson,20
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis,https://clincancerres.aacrjournals.org/content/11/10/3647.short,"Q Jin, K Hemminki, K Enquist, P Lenner… ","Clinical cancer …, 2005 ","Purpose: Angiogenesis is a necessary step in tumor growth and metastasis. Vascular 
endothelial growth factor (VEGF) is a major mediator of breast cancer angiogenesis. Therefore, 
we investigated the association of polymorphisms in the VEGF gene with breast cancer risk and …",Roger Henriksson,20
[HTML][HTML] Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide …,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015426/,"T Sandmann, R Bourgon, J Garcia, C Li… ","Journal of clinical …, 2015 ","Purpose The AVAglio (Avastin in Glioblastoma) and RTOG-0825 randomized, placebo-controlled 
phase III trials in newly diagnosed glioblastoma reported prolonged progression-free 
survival (PFS), but not overall survival (OS), with the addition of bevacizumab to radiotherapy …",Roger Henriksson,20
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.,https://ascopubs.org/doi/abs/10.1200/JCO.1998.16.9.3121,"B Linderholm, B Tavelin, K Grankvist… ","Journal of Clinical …, 1998 ","PURPOSE The prognostic value of vascular endothelial growth factor (VEGF) protein, known 
to stimulate endothelial growth and angiogenesis, was evaluated in node-negative breast 
carcinoma (NNBC) and compared with established prognostic factors. PATIENTS AND …",Roger Henriksson,20
[HTML][HTML] Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology,https://www.sciencedirect.com/science/article/pii/S1470204515000765,"K Hoang-Xuan, E Bessell, J Bromberg, AF Hottinger… ","The Lancet …, 2015 ","The management of primary CNS lymphoma is one of the most controversial topics in neuro-oncology 
because of the complexity of the disease and the very few controlled studies available. In 
2013, the European Association of Neuro-Oncology created a multidisciplinary task …",Roger Henriksson,20
[PDF][PDF] Genome-wide association study of glioma and meta-analysis,https://link.springer.com/content/pdf/10.1007/s00439-012-1212-0.pdf,"P Rajaraman, BS Melin, Z Wang, R McKean-Cowdin… ","Human genetics, 2012 ","Gliomas account for approximately 80 % of all primary malignant brain tumors and, despite 
improvements in clinical care over the last 20 years, remain among the most lethal tumors, 
underscoring the need for gaining new insights that could translate into clinical advances. …",Roger Henriksson,20
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker,https://academic.oup.com/carcin/article-abstract/29/7/1394/2476750,"A Brendle, H Lei, A Brandt, R Johansson… ","…, 2008 ","Integrins control the cell attachment to the extracellular matrix and play an important role in 
mediating cell proliferation, migration and survival. A number of important cancer-associated 
integrin genes can be regulated by microRNAs (miRNAs) that bind to their target sites in the 3…",Roger Henriksson,20
The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer,https://cancerres.aacrjournals.org/content/61/5/2256.short,"BK Linderholm, T Lindahl, L Holmberg, S Klaar… ","Cancer research, 2001 ","Wild-type p53 protein has been shown to inhibit angiogenesis through thrombospondin in 
the preclinical setting. Here, we determined the associations between the expression of the 
angiogenic factor vascular endothelial growth factor (VEGF) and the p53 status, including …",Roger Henriksson,20
Breast cancer survival is associated with telomere length in peripheral blood cells,https://cancerres.aacrjournals.org/content/68/10/3618.short,"U Svenson, K Nordfjäll, B Stegmayr, J Manjer… ","Cancer research, 2008 ","Telomeres are essential for maintaining chromosomal stability. Previous studies have indicated 
that individuals with shorter blood telomeres may be at higher risk of developing various 
types of cancer, such as in lung, bladder, and kidney. We have analyzed relative telomere …",Roger Henriksson,20
"Cloning, characterization, and expression of human LIG1",https://www.sciencedirect.com/science/article/pii/S0006291X01950922,"J Nilsson, C Vallbo, D Guo, I Golovleva… ","Biochemical and …, 2001 ","Growth factor receptors are frequently amplified and over-expressed in various human 
cancers. Recently, a Drosophila cell surface protein, Kekkon-1, was found to participate in an 
epidermal growth factor (EGF) driven negative feedback loop. Kekkon-1 is induced by EGF, …",Roger Henriksson,20
[HTML][HTML] Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study,https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-019-2452-5,"K Wode, R Henriksson, L Sharp… ","BMC …, 2019 ","Access to and advice on Complementary and Alternative Medicine (CAM) are uncommon 
within Swedish conventional cancer care and little is known about cancer patients’ own use of 
CAM. The aim of this cross-sectional study was to explore Swedish cancer patients patterns …",Roger Henriksson,30
"[HTML][HTML] Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review",https://link.springer.com/article/10.1007/s11060-011-0565-x,"R Henriksson, T Asklund, HS Poulsen ","Journal of neuro-oncology, 2011 ","The maintenance of quality of life (QoL) in patients with high-grade glioma is an important 
endpoint during treatment, particularly in those with glioblastoma multiforme (GBM) given its 
dismal prognosis despite limited advances in standard therapy. It has proven difficult to identify …",Roger Henriksson,30
"[HTML][HTML] Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas",https://link.springer.com/article/10.1007/s00401-004-0875-6,"U Andersson, D Guo, B Malmer, AT Bergenheim… ","Acta …, 2004 ","Overexpression of epidermal growth factor receptor (EGFR, ErbB1) correlates with enhanced 
malignant potential of many human tumor types including glioblastoma multiforme. The 
significance of EGFR expression in meningiomas is, however, unclear. Reports regarding the …",Roger Henriksson,30
p53 and vascular‐endothelial‐growth‐factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma,https://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(20000120)89:1%3C51::AID-IJC9%3E3.0.CO;2-8,"B Linderholm, B Lindh, B Tavelin… ","… journal of cancer, 2000 ","The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary 
breast carcinoma. Alteration of the p53 gene causes down‐regulation of the expression 
of thrombospondin‐1, a natural inhibitor of angiogenesis. This study was conducted to …",Roger Henriksson,30
"EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours",https://www.annalsofoncology.org/article/S0923-7534(19)42149-2/abstract,"E Le Rhun, M Weller, D Brandsma… ","Annals of …, 2017 ","These EANO–ESMO joint recommendations for the diagnosis and treatment of leptomeningeal 
metastasis (LM) from solid cancers represent the first European guideline initiative on 
this topic. LM is defined as the spread of tumour cells within the leptomeninges and the …",Roger Henriksson,30
The creation of protection and hope in patients with malignant brain tumours,https://www.sciencedirect.com/science/article/pii/0277953695002049,"P Salander, T Bergenheim, R Henriksson ","Social science & medicine, 1996 ","The malignant brain tumour disease condenses much of the anguish of cancer diseases. The 
brain is a vital and delicate organ, and the prognosis is generally unfavourable. The patient 
is exposed and has to rely on cognitive manoeuvres to manage the mental stress. The …",Roger Henriksson,30
Scheduling garbage collection in embedded systems,https://portal.research.lu.se/portal/en/publications/scheduling-garbage-collection-in-embedded-systems(875967b6-fe80-433a-a2bd-82bf1b147848).html,R Henriksson ,1998 ,"The complexity of systems for automatic control and other safety-critical applications grows 
rapidly. Computer software represents an increasing part of the complexity. As larger systems 
are developed, we need to find scalable techniques to manage the complexity in order to …",Roger Henriksson,30
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden,https://link.springer.com/article/10.1007/BF02699940,"J Capala, H Britta, K Sköld, V Giusti, C Persson… ","Journal of neuro …, 2003 ","A boron neutron capture therapy (BNCT) facility has been constructed at Studsvik, Sweden. 
It includes two filter/moderator configurations. One of the resulting neutron beams has been 
optimized for clinical irradiations with a filter/moderator system that allows easy variation of …",Roger Henriksson,30
Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types,https://academic.oup.com/jnci/article-abstract/107/12/djv279/2457731,"JN Sampson, WA Wheeler, M Yeager… ","JNCI: Journal of the …, 2015 ","Background: Studies of related individuals have consistently demonstrated notable familial 
aggregation of cancer. We aim to estimate the heritability and genetic correlation attributable 
to the additive effects of common single-nucleotide polymorphisms (SNPs) for cancer at 13 …",Roger Henriksson,30
[HTML][HTML] European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma,https://www.sciencedirect.com/science/article/pii/S1470204517303455,"A Pace, L Dirven, JAF Koekkoek, H Golla, J Fleming… ","The Lancet …, 2017 ","Patients with glioma present with complex palliative care needs throughout their disease 
trajectory. The life-limiting nature of gliomas and the presence of specific symptoms related to 
neurological deterioration necessitate an appropriate and early palliative care approach. The …",Roger Henriksson,30
[HTML][HTML] Large-scale genotyping identifies 41 new loci associated with breast cancer risk,https://www.nature.com/articles/ng.2563,"K Michailidou, P Hall, A Gonzalez-Neira… ","Nature …, 2013 ","Breast cancer is the most common cancer among women. Common variants at 27 loci have 
been identified as associated with susceptibility to breast cancer, and these account for∼ 9% 
of the familial risk of the disease. We report here a meta-analysis of 9 genome-wide …",Sara Margolin,10
[HTML][HTML] Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer,https://www.nature.com/articles/ng2064,"SN Stacey, A Manolescu, P Sulem, T Rafnar… ","Nature …, 2007 ","Familial clustering studies indicate that breast cancer risk has a substantial genetic 
component 1, 2, 3. To identify new breast cancer risk variants, we genotyped approximately 
300,000 SNPs in 1,600 Icelandic individuals with breast cancer and 11,563 controls using the …",Sara Margolin,10
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies,https://academic.oup.com/jnci/article-abstract/103/3/250/2517238,"XR Yang, J Chang-Claude, EL Goode… ","Journal of the …, 2011 ","Background Previous studies have suggested that breast cancer risk factors are associated 
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors. 
Methods We pooled tumor marker and epidemiological risk factor data from 35 568 invasive …",Sara Margolin,10
"[HTML][HTML] Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer",https://www.nature.com/articles/ng.3242,"K Michailidou, J Beesley, S Lindstrom, S Canisius… ","Nature …, 2015 ","Genome-wide association studies (GWAS) and large-scale replication studies have identified 
common variants in 79 loci associated with breast cancer, explaining∼ 14% of the familial 
risk of the disease. To identify new susceptibility loci, we performed a meta-analysis of 11 …",Sara Margolin,10
"Breast Cancer Risk Genes-Association Analysis in More than 113,000 Women.",https://europepmc.org/article/pmc/pmc7611105,"L Dorling, S Carvalho, J Allen… ","The New England …, 2021 ","Background Genetic testing for breast cancer susceptibility is widely used, but for many genes, 
evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, 
and reliable subtype-specific risk estimates are lacking. Methods We used a panel of …",Sara Margolin,10
Prediction of breast cancer risk based on profiling with common genetic variants,https://academic.oup.com/jnci/article-abstract/107/5/djv036/891009,"N Mavaddat, PDP Pharoah… ","JNCI: Journal of the …, 2015 ","Background: Data for multiple common susceptibility alleles for breast cancer may be 
combined to identify women at different levels of breast cancer risk. Such stratification could 
guide preventive and screening strategies. However, empirical evidence for genetic risk …",Sara Margolin,10
[HTML][HTML] Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer,https://www.nature.com/articles/ng.131,"SN Stacey, A Manolescu, P Sulem, S Thorlacius… ","Nature …, 2008 ","We carried out a genome-wide association study of breast cancer predisposition with 
replication and refinement studies involving 6,145 cases and 33,016 controls and identified two 
SNPs (rs4415084 and rs10941679) on 5p12 that confer risk, preferentially for estrogen receptor …",Sara Margolin,10
[HTML][HTML] Newly discovered breast cancer susceptibility loci on 3p24 and 17q23. 2,https://www.nature.com/articles/ng.354,"S Ahmed, G Thomas, M Ghoussaini, CS Healey… ","Nature …, 2009 ","Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility 
loci, but these explain only a small fraction of the familial risk of the disease. Five of these 
loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls …",Sara Margolin,10
[HTML][HTML] Genome-wide association studies identify four ER negative–specific breast cancer risk loci,https://www.nature.com/articles/ng.2561,"M Garcia-Closas, FJ Couch, S Lindstrom… ","Nature …, 2013 ","Estrogen receptor (ER)-negative tumors represent 20–30% of all breast cancers, with a 
higher proportion occurring in younger women and women of African ancestry 1. The etiology 
2 and clinical behavior 3 of ER-negative tumors are different from those of tumors expressing …",Sara Margolin,10
[HTML][HTML] A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer,https://www.nature.com/articles/ng.985,"CA Haiman, GK Chen, CM Vachon, F Canzian… ","Nature …, 2011 ","Estrogen receptor (ER)-negative breast cancer shows a higher incidence in women of African 
ancestry compared to women of European ancestry. In search of common risk alleles for 
ER-negative breast cancer, we combined genome-wide association study (GWAS) data from …",Sara Margolin,10
[HTML][HTML] Genome-wide association analysis identifies three new breast cancer susceptibility loci,https://www.nature.com/articles/ng.1049,"M Ghoussaini, O Fletcher, K Michailidou, C Turnbull… ","Nature …, 2012 ","Breast cancer is the most common cancer among women. To date, 22 common breast cancer 
susceptibility loci have been identified accounting for∼ 8% of the heritability of the disease. 
We attempted to replicate 72 promising associations from two independent genome-wide …",Sara Margolin,20
"[HTML][HTML] Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair",https://www.nature.com/articles/ng.3412,"FR Day, KS Ruth, DJ Thompson, KL Lunetta… ","Nature …, 2015 ","Menopause timing has a substantial impact on infertility and risk of disease, including breast 
cancer, but the underlying mechanisms are poorly understood. We report a dual strategy in∼ 
70,000 women to identify common and low-frequency protein-coding variation associated …",Sara Margolin,20
"E‐readers, computer screens, or paper: Does reading comprehension change across media platforms?",https://onlinelibrary.wiley.com/doi/abs/10.1002/acp.2930,"SJ Margolin, C Driscoll, MJ Toland… ","Applied cognitive …, 2013 ","The present research examined the impact of technology on reading comprehension. While 
previous research has examined memory for text, and yielded mixed results of the impact 
technology has on one's ability to remember what they have read, the reading literature has not …",Sara Margolin,20
"[HTML][HTML] A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer",https://www.nature.com/articles/s41588-018-0132-x,"L Wu, W Shi, J Long, X Guo, K Michailidou, J Beesley… ","Nature …, 2018 ","The breast cancer risk variants identified in genome-wide association studies explain only a 
small fraction of the familial relative risk, and the genes responsible for these associations 
remain largely unknown. To identify novel risk loci and likely causal genes, we performed a …",Sara Margolin,20
[HTML][HTML] Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers,https://www.sciencedirect.com/science/article/pii/S0002929713000311,"JD French, M Ghoussaini, SL Edwards… ","The American Journal of …, 2013 ","Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified 
three independent association signals for estrogen-receptor-positive tumors at 11q13. The 
strongest signal maps to a transcriptional enhancer element in which the G allele of the best …",Sara Margolin,20
"CEREBEL (EGF111438): a phase III, randomized, open-label study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with human …",https://ascopubs.org/doi/abs/10.1200/jco.2014.57.1794,"X Pivot, A Manikhas, B Żurawski… ","Journal of Clinical …, 2015 ","Purpose CEREBEL compared the incidence of CNS metastases as first site of relapse in 
patients with human epidermal growth factor receptor 2–positive metastatic breast cancer 
receiving lapatinib-capecitabine or trastuzumab-capecitabine. Patients and Methods Patients …",Sara Margolin,20
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium,https://academic.oup.com/hmg/article-abstract/20/16/3289/648706,"A Broeks, MK Schmidt, ME Sherman… ","Human molecular …, 2011 ","Breast cancers demonstrate substantial biological, clinical and etiological heterogeneity. We 
investigated breast cancer risk associations of eight susceptibility loci identified in GWAS 
and two putative susceptibility loci in candidate genes in relation to specific breast tumor …",Sara Margolin,20
"[HTML][HTML] PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS",https://jmg.bmj.com/content/53/12/800.short,"MC Southey, DE Goldgar, R Winqvist… ","Journal of medical …, 2016 ","Background The rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate 
precisely associated cancer risks. Population-based family studies have provided evidence 
that at least some of these mutations are associated with breast cancer risk as high as those …",Sara Margolin,20
"[HTML][HTML] CHEK2* 1100delC heterozygosity in women with breast cancer associated with early death, breast cancer–specific death, and increased risk of a second …",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515767/,"M Weischer, BG Nordestgaard, P Pharoah… ","Journal of clinical …, 2012 ","… Beckmann, Argyrios Ziogas, Marie-Rose Christiaens, Johanna Margriet Collée, Malcolm 
WR Reed, Gianluca Severi, Frederik Marme, Sara Margolin, Janet E. Olson, Veli-Matti 
Kosma, Vessela N. Kristensen, Alexander Miron, Natalia Bogdanova, Mitul Shah, Carl …",Sara Margolin,20
[HTML][HTML] Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk,https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1003173,"MM Gaudet, KB Kuchenbaecker, J Vijai, RJ Klein… ","PLoS …, 2013 ","Common genetic variants contribute to the observed variation in breast cancer risk for 
BRCA2 mutation carriers; those known to date have all been found through population-based 
genome-wide association studies (GWAS). To comprehensively identify breast cancer risk …",Sara Margolin,20
[HTML][HTML] Age-and tumor subtype–specific breast cancer risk estimates for CHEK2* 1100delC carriers,https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5019754/,"MK Schmidt, F Hogervorst, R Van Hien… ","Journal of clinical …, 2016 ","Purpose CHEK2* 1100delC is a well-established breast cancer risk variant that is most 
prevalent in European populations; however, there are limited data on risk of breast cancer by 
age and tumor subtype, which limits its usefulness in breast cancer risk prediction. We aimed to …",Sara Margolin,30
[HTML][HTML] Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the …,https://link.springer.com/article/10.1007/s10549-017-4571-3,"S Mijwel, M Backman, KA Bolam, A Jervaeus… ","Breast cancer research …, 2018 ","Purpose Exercise training is an effective and safe way to counteract cancer-related fatigue (CRF) 
and to improve health-related quality of life (HRQoL). High-intensity interval training has 
proven beneficial for the health of clinical populations. The aim of this randomized …",Sara Margolin,30
Common breast cancer susceptibility loci are associated with triple-negative breast cancer,https://cancerres.aacrjournals.org/content/71/19/6240.short,"KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick… ","Cancer research, 2011 ","Triple-negative breast cancers are an aggressive subtype of breast cancer with poor survival, 
but there remains little known about the etiologic factors that promote its initiation and 
development. Commonly inherited breast cancer risk factors identified through genome-wide …",Sara Margolin,30
[HTML][HTML] Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1,https://www.sciencedirect.com/science/article/pii/S0002929713004837,"KB Meyer, M O'Reilly, K Michailidou, S Carlebur… ","The American Journal of …, 2013 ","The 10q26 locus in the second intron of FGFR2 is the locus most strongly associated with 
estrogen-receptor-positive breast cancer in genome-wide association studies. We 
conducted fine-scale mapping in case-control studies genotyped with a custom chip (iCOGS), …",Sara Margolin,30
Height and breast cancer risk: evidence from prospective studies and Mendelian randomization,https://academic.oup.com/jnci/article-abstract/107/11/djv219/2457671,"B Zhang, XO Shu, RJ Delahanty, C Zeng… ","Journal of the …, 2015 ","Background: Epidemiological studies have linked adult height with breast cancer risk in 
women. However, the magnitude of the association, particularly by subtypes of breast cancer, 
has not been established. Furthermore, the mechanisms of the association remain unclear. …",Sara Margolin,30
19p13. 1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus,https://cancerres.aacrjournals.org/content/72/7/1795.short,"KN Stevens, Z Fredericksen, CM Vachon, X Wang… ","Cancer research, 2012 ","The 19p13.1 breast cancer susceptibility locus is a modifier of breast cancer risk in BRCA1 
mutation carriers and is also associated with the risk of ovarian cancer. Here, we investigated 
19p13.1 variation and risk of breast cancer subtypes, defined by estrogen receptor (ER), …",Sara Margolin,30
[HTML][HTML] Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation,https://www.nature.com/articles/ncomms5999,"M Ghoussaini, SL Edwards, K Michailidou… ","Nature …, 2014 ","GWAS have identified a breast cancer susceptibility locus on 2q35. Here we report the fine 
mapping of this locus using data from 101,943 subjects from 50 case-control studies. We 
genotype 276 SNPs using the ‘iCOGS’genotyping array and impute genotypes for a further 1,284 …",Sara Margolin,30
[HTML][HTML] Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer,https://www.nature.com/articles/ncomms11375,"FJ Couch, KB Kuchenbaecker, K Michailidou… ","Nature …, 2016 ","Common variants in 94 loci have been associated with breast cancer including 15 loci with 
genome-wide significant associations (P< 5× 10− 8) with oestrogen receptor (ER)-negative 
breast cancer and BRCA1-associated breast cancer risk. In this study, to identify new ER-…",Sara Margolin,30
"[HTML][HTML] Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent",https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002105,"Y Guo, S Warren Andersen, XO Shu… ","PLoS …, 2016 ","Background Observational epidemiological studies have shown that high body mass index (BMI) 
is associated with a reduced risk of breast cancer in premenopausal women but an 
increased risk in postmenopausal women. It is unclear whether this association is mediated …",Sara Margolin,30
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing,https://jmg.bmj.com/content/53/5/298.short,"DF Easton, F Lesueur, B Decker… ","Journal of medical …, 2016 ","Background BRCA1 interacting protein C-terminal helicase 1 (BRIP1) is one of the Fanconi 
Anaemia Complementation (FANC) group family of DNA repair proteins. Biallelic mutations 
in BRIP1 are responsible for FANC group J, and previous studies have also suggested that …",Sara Margolin,30
Is a deep response the key to successful treatment of multiple myeloma?,https://research.rug.nl/en/publications/is-a-deep-response-the-key-to-successful-treatment-of-multiple-my,"J Liwing, BM Heeg, S Karstorp, M Postma… ","…, 2015 ","Background: Several authors have highlighted the importance of a deep response to 
chemotherapy in multiple myeloma (MM), especially in first line. Aims: The objective was to assess 
which patient/treatment/disease characteristics are prognostic for a deep response. Also, to …",Sigrid Karstorp,6
The rev II Trial: lenalidomide and dexamethasone as second line treatment in myeloma followed by extended lenalidomid vs Len/Dex,https://ashpublications.org/blood/article-abstract/126/23/3047/135574,"J Lund, S Karstorp, E Alici, A Gruber, B Lauri, C Blimark… ",2015 ,"Background The indication for use of lenalidomide in second line of therapy has been based 
upon two phase III studies comparing lenalidomide and dexamethasone vs. placebo and 
dexamethasone (Weber 2007, Dimopoulos 2007) showing a TTP of 11.1 and 11.3 months …",Sigrid Karstorp,6
Can overall survival be improved in elderly multiple myeloma patients?,https://research.rug.nl/en/publications/can-overall-survival-be-improved-in-elderly-multiple-myeloma-pati,"BM Heeg, J Liwing, S Karstorp, M Postma… ","…, 2015 ","Background: The ongoing introduction of novel therapies for MM provides clinicians and 
patients various treatment options in numerous lines of treatment. Understanding the 
current treatment practices and the outcomes in different age groups is of vital importance to …",Sigrid Karstorp,6
Trial efficacy vs real world effectiveness in first line treatment of multiple myeloma,https://research.rug.nl/en/publications/trial-efficacy-vs-real-world-effectiveness-in-first-line-treatmen,"J Liwing, BM Heeg, S Karstorp, M Postma… ","…, 2015 ","Background: Large randomized clinical trials (RCT) are the foundation of the registration of 
newly developed drugs. A potential problem with RCTs is that the inclusion/exclusion criteria 
will make the population different from the actual population treated in real life. Hence, it is …",Sigrid Karstorp,6
Clinical studies in multiple myeloma,https://openarchive.ki.se/xmlui/handle/10616/45263,J Lund ,2016 ,"Multiple Myeloma (MM) is an incurably disease of the bone marrow. It is characterized by 
the uncontrolled growth of clonal plasma cells (PCs) and leads to production of non-functional 
gammaglobulin. Clinical features include loss of normal bone marrow function, defect bone …",Sigrid Karstorp,6
[BOOK][B] Progression of RNA-sequencing to single-cell applications,https://openarchive.ki.se/xmlui/handle/10616/41981,D Ramsköld ,2014 ,"… Both I and a master thesis student in our group, Sigrid Karstorp, tried the protocol95 but it 
would not work; neither of us got amplified cDNA out of it. Meanwhile, I tried to get my re-analysis 
of the Tang et al. 200994 data published, but failed (rejected by two journals, then we gave …",Sigrid Karstorp,6
,,,,,Sigrid Karstorp,6
,,,,,Sigrid Karstorp,6
Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer …,https://www.tandfonline.com/doi/abs/10.3109/21681805.2016.1172254,"J Svensson, E Andersson, U Persson… ","… journal of urology, 2016 ","Objective: In a randomized clinical trial (COU-AA-301), abiraterone acetate (Zytiga ® ) was 
shown to be superior to prednisone in the treatment of metastatic castration-resistant prostate 
cancer (mCRPC). However, the value of abiraterone treatment for patients with mCRPC in …",Thomas Edekling,10
[HTML][HTML] Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor,https://bmcclinpathol.biomedcentral.com/articles/10.1186/1472-6890-9-8,"M Jönsson, A Ekstrand… ","BMC clinical …, 2009 ","KRAS mutations represent key alterations in colorectal cancer development and lead to 
constitutive EGFR signaling. Since EGFR inhibition represents a therapeutic strategy in 
advanced colorectal cancer, KRAS mutation analysis has quickly been introduced as a treatment-…",Thomas Edekling,10
Erythropoietin Treatment in Metastatic Breast Cancer,https://www.tandfonline.com/doi/abs/10.1080/02841860214960,"AM Olsson, JH Svensson, J Sundström… ","Acta …, 2002 ","Erythropoietin is an effective treatment for anemia in patients with various types of cancers, 
but few studies have evaluated the benefit of treatment in advanced breast cancer. In this 
multicenter study, we investigated the influence of two different doses of epoetin-beta on the …",Thomas Edekling,10
[PDF][PDF] SNAR POSTOPERATIV TERAPI FÖRLÄNGER SYMTOMFRI TID,https://lakartidningen.se/wp-content/uploads/OldPdfFiles/1997/16353.pdf,"R HENRIKSSON, G BERG, L ANDREASSON… ",lakartidningen.se,"DEBATT. ’’… att enbart ge strålning palliativt när patienten väl har symtom är felaktigt och 
skulle bidra till att en stor del patienter undandras en behandling som de skulle ha nytta av.’’skillnad 
mellan grad III-och IV-tumörer och mellan yngre och äldre patienter med grad IV [5]. I …",Thomas Edekling,10
[HTML][HTML] Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden,https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1448902/,"P Viklund, M Lindblad, M Lu, W Ye, J Johansson… ","Annals of …, 2006 ","Objective: To identify risk factors for complications after resection for esophageal or cardia 
cancer. Summary Background Data: Knowledge of risk factors for complications after esophageal 
resection for cancer is sparse, and prospective population-based studies are lacking. …",Thomas Edekling,10
[HTML][HTML] Quality of life and persisting symptoms after oesophageal cancer surgery,https://www.sciencedirect.com/science/article/pii/S0959804906002590,"P Viklund, Y Wengström, I Rouvelas, M Lindblad… ","European Journal of …, 2006 ","To assess quality of life (QoL) and symptoms after oesophageal cancer surgery, a prospective 
nationwide population-based study was conducted in 2001–2005, including most surgically 
treated oesophageal cancer patients in Sweden. Six months postoperatively patients …",Thomas Edekling,10
[HTML][HTML] Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection,https://link.springer.com/article/10.1007/s00268-005-7887-9,"P Viklund, M Lindblad, J Lagergren ","World journal of surgery, 2005 ","Abstract Knowledge of how factors related to esophageal cancer resection affect long-term 
quality of life after surgery is scarce, and no population-based studies are available. 
Therefore, we conducted a Swedish nationwide, prospective, population-based study of how …",Thomas Edekling,10
[HTML][HTML] A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de …,https://www.sciencedirect.com/science/article/pii/S0923753419418450,"B Glimelius, H Sørbye, L Balteskard, P Byström… ","Annals of oncology, 2008 ","Background To compare irinotecan with the Nordic 5-fluorouracil (5-FU) and folinic acid (FA) 
bolus schedule [irinotecan 180 mg/m 2 on day 1, 5-FU 500 mg/m 2 and FA 60 mg/m 2 on day 
1 and 2 (FLIRI)] or the Lv5FU2 schedule [irinotecan 180 mg/m 2 on day 1, FA 200 mg/m 2 , …",Thomas Edekling,10
[HTML][HTML] No influence of surgical volume on patients' health-related quality of life after esophageal cancer resection,https://link.springer.com/article/10.1245/s10434-008-9964-4,"M Rutegård, P Lagergren ","Annals of surgical oncology, 2008 ","Background Studies on factors that can counteract the negative impact of esophagectomy on 
patients’ health-related quality of life (HRQL) have been sparse. This study was undertaken 
to examine the question whether hospital or surgeon volume influences HRQL as evaluated …",Thomas Edekling,10
[HTML][HTML] Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice,https://www.sciencedirect.com/science/article/pii/S2213089616060011,"F Cardoso, M Colleoni, A Di Leo, G Francia… ","Cancer Treatment …, 2016 ","Metastatic breast cancer (MBC) is quite sensitive to chemotherapy, with patients often benefiting 
from multiple lines of treatment. Continuation of chemotherapy until disease progression, 
if tolerable, prolongs disease control and improves patient outcomes. Compared to …",Thomas Edekling,10
[PDF][PDF] ledare,http://www.onkologiisverige.se/wp-content/uploads/2014/02/OIS_2_07.pdf,S Nilsson ,2002 ,"Kära vänner, Tiden går verkligen fort och det är återigen dags för Onkologidagarna. Dessa 
är Svensk Onkologisk Förenings stora vårevenemang och går i år av stapeln i Malmö-Lund 
med Annika Håkansson, Gunnar Westman och Carsten Rose som värdar. Programmet ser i …",Thomas Edekling,11
,,,,,Thomas Edekling,11
[HTML][HTML] Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing,https://www.sciencedirect.com/science/article/pii/S0092867418303659,"C Kim, R Gao, E Sei, R Brandt, J Hartman, T Hatschek… ","Cell, 2018 ","Triple-negative breast cancer (TNBC) is an aggressive subtype that frequently develops 
resistance to chemotherapy. An unresolved question is whether resistance is caused by the 
selection of rare pre-existing clones or alternatively through the acquisition of new genomic …",Thomas Hatschek,10
"[PDF][PDF] Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout …",https://www.researchgate.net/profile/Ulla-Wilking/publication/227343718_Clinically_Used_Breast_Cancer_Markers_Such_As_Estrogen_Receptor_Progesterone_Receptor_and_Human_Epidermal_Growth_Factor_Receptor_2_Are_Unstable_Throughout_Tumor_Progression/links/554756610cf24107d39836e4/Clinically-Used-Breast-Cancer-Markers-Such-As-Estrogen-Receptor-Progesterone-Receptor-and-Human-Epidermal-Growth-Factor-Receptor-2-Are-Unstable-Throughout-Tumor-Progression.pdf,"LS Lindstrom, E Karlsson, UM Wilking, U Johansson… ","J Clin …, 2012 ","… Wilking, Ulla Johansson, Johan Hartman, Elisabet Kerstin Lidbrink, Thomas Hatschek, 
Lambert Skoog, and Jonas Bergh … Kerstin Lidbrink, Thomas Hatschek, Lambert Skoog, 
and Jonas Bergh, Cancer … Wilking, Ulla Johansson, Johan Hartman, Elisabet Kerstin …",Thomas Hatschek,10
[HTML][HTML] An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression,https://www.sciencedirect.com/science/article/pii/S1535610817304567,"A Palazon, PA Tyrakis, D Macias, P Veliça… ","Cancer cell, 2017 ","Cytotoxic T cells infiltrating tumors are thought to utilize HIF transcription factors during 
adaptation to the hypoxic tumor microenvironment. Deletion analyses of the two key HIF 
isoforms found that HIF-1α, but not HIF-2α, was essential for the effector state in CD8 + T cells. …",Thomas Hatschek,10
Radiologic measurements of tumor response to treatment: practical approaches and limitations,https://pubs.rsna.org/doi/abs/10.1148/rg.282075068,"C Suzuki, H Jacobsson, T Hatschek, MR Torkzad… ","Radiographics, 2008 ","Objective response assessment is important to describe the treatment effect of anticancer 
drugs. Standardization by using a “common language” is also important for comparison of 
results from different trials. In contrast to clinical results, which can be subjective, diagnostic …",Thomas Hatschek,10
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma,https://www.sciencedirect.com/science/article/pii/014067369292558W,"XF Sun, JM Carstensen, O Stål, S Wingren, T Hatschek… ","The Lancet, 1992 ","Mutation of p53, a tumour-suppressor protein, leads to overexpression of the protein and loss 
of its tumour-suppressive properties. In some tumours (eg, breast) p53 expression is related 
to well-known prognostic factors, but findings in colorectal tumours are equivocal. We have …",Thomas Hatschek,10
[HTML][HTML] HER2 status in a population-derived breast cancer cohort: discordances during tumor progression,https://link.springer.com/article/10.1007/s10549-010-1029-2,"U Wilking, E Karlsson, L Skoog, T Hatschek… ","Breast cancer research …, 2011 ","This retrospective study investigates the correlation of intra-individual HER2 status between 
primary breast cancers and corresponding recurrences in a population derived cohort. The 
REMARK criteria were used as reference. In 151 breast cancer patients, primary tumors were …",Thomas Hatschek,10
Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria,https://www.tandfonline.com/doi/abs/10.3109/02841861003705794,"C Suzuki, MR Torkzad, H Jacobsson, G Åström… ","Acta …, 2010 ","Background. Response Evaluation Criteria In Solid Tumors (RECIST) and WHO-criteria are 
used to evaluate treatment effects in clinical trials. The purpose of this study was to examine 
interobserver and intraobserver variations in radiological response assessment using these …",Thomas Hatschek,10
[HTML][HTML] Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival,https://www.sciencedirect.com/science/article/pii/S0923753419313389,"NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt… ","Annals of oncology, 2015 ","Background We and others have recently shown that tumor characteristics are altered 
throughout tumor progression. These findings emphasize the need for re-examination of tumor 
characteristics at relapse and have led to recommendations from ESMO and the Swedish …",Thomas Hatschek,10
Determinants of papillary cancer of the thyroid,https://academic.oup.com/aje/article-abstract/138/7/482/151527,"G Wingren, T Hatschek, O Axelson ","American journal of …, 1993 ","Determinants of papillary thyroid cancer were evaluated in a questionnaire-based case-control 
study from southeastern Sweden. A total of 104 cases, diagnosed from 1977 to 1987, and 
387 randomly selected controls were included in the analyses. Female subjects with …",Thomas Hatschek,10
[HTML][HTML] No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions–results from a randomised blinded trial,https://www.sciencedirect.com/science/article/pii/S1462388912001202,"L Sharp, K Finnilä, H Johansson… ","European Journal of …, 2013 ","Purpose The purpose of this blinded, randomized clinical trial was to compare two topical 
agents (Calendula Weleda ® cream vs. Essex ® cream) in reducing the risk of severe acute 
radiation skin reactions (ARSR) in relation to adjuvant radiotherapy (RT) for breast cancer. …",Thomas Hatschek,10
[HTML][HTML] Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer,https://www.sciencedirect.com/science/article/pii/S0960977613002129,"L Sharp, H Johansson, T Hatschek, M Bergenmar ","The Breast, 2013 ","Risk factors for severe acute radiation skin reactions (ARSR) have been described with 
conflicting results. The aim of this study was to identify risk factors for the development of severe 
ARSR in women undergoing adjuvant radiotherapy (RT) for breast cancer. 390 women were …",Thomas Hatschek,20
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels,https://link.springer.com/article/10.1023/A:1006332423620,"M Fernö, O Stål, B Baldetrop, T Hatschek… ","Breast cancer research …, 2000 ","A Swedish cooperative trial demonstrated that 5 years of adjuvant tamoxifen was more 
beneficial than 2 years of tamoxifen in the treatment of postmenopausal women with estrogen 
receptor (ER) positive, early stage, invasive breast cancer. The main aim of the present study …",Thomas Hatschek,20
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial,https://academic.oup.com/jnci/article-abstract/97/21/1609/2521459,"B Nordenskjöld, J Rosell, LE Rutqvist… ","Journal of the …, 2005 ","From January 1, 1983, through December 31, 1992, a total of 4610 patients entered a 
randomized trial that compared mortality among patients receiving 2 years of adjuvant tamoxifen 
therapy with that in patients receiving 5 years of adjuvant tamoxifen therapy, 4175 of whom …",Thomas Hatschek,20
Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus …,https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31070,"S Kimbung, I Markholm, J Bjöhle… ","… journal of cancer, 2018 ","Pathologic complete response (pCR) is a predictor for favorable outcome after neoadjuvant 
treatment in early breast cancer. Modulation of gene expression may also provide early 
readouts of biological activity and prognosis, offering the possibility for timely response‐guided …",Thomas Hatschek,20
[HTML][HTML] Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences,https://www.sciencedirect.com/science/article/pii/S1574789113001427,"S Kimbung, A Kovács, PO Bendahl, P Malmström… ","Molecular …, 2014 ","Background Predicting any future metastatic site of early-stage breast cancer is important as it 
significantly influences the prognosis of advanced disease. This study aimed at investigating 
the potential of claudin-2, over-expressed in breast cancer liver metastases, as a …",Thomas Hatschek,20
"Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer: a phase 2 randomized clinical trial",https://jamanetwork.com/journals/jamaoncology/article-abstract/2781086,"T Hatschek, T Foukakis, J Bjöhle, T Lekberg… ","JAMA …, 2021 ","Importance Trastuzumab emtansine (T-DM1) is presently approved for treatment of advanced 
breast cancer and after incomplete response to neoadjuvant therapy, but the potential of 
T-DM1 as monotherapy is so far unknown. Objective To assess pathologic complete response …",Thomas Hatschek,20
Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care,https://www.tandfonline.com/doi/abs/10.1080/02841860310020339,"M Carlsson, M Arman, M Backman, U Flatters… ","Acta …, 2004 ","The aim was to study the perceived quality of life/life satisfaction in a sample of women with 
breast cancer who were treated in a hospital with alternative/complementary care and the 
same variables in individually matched patients who received only conventional medical …",Thomas Hatschek,20
[HTML][HTML] Separation of breast cancer and organ microenvironment transcriptomes in metastases,https://link.springer.com/article/10.1186/s13058-019-1123-2,"MA Alzubi, TH Turner, AL Olex, SS Sohal… ","Breast Cancer …, 2019 ","The seed and soil hypothesis was proposed over a century ago to describe why cancer 
cells (seeds) grow in certain organs (soil). Since then, the genetic properties that define the 
cancer cells have been heavily investigated; however, genomic mediators within the organ …",Thomas Hatschek,20
[HTML][HTML] Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741767/,"S Kimbung, A Kovács, A Danielsson, PO Bendahl… ","Oncotarget, 2015 ","The relevance of the intrinsic subtypes for clinical management of metastatic breast cancer 
is not comprehensively established. We aimed to evaluate the prevalence and prognostic 
significance of drifts in tumor molecular subtypes during breast cancer progression. A well-…",Thomas Hatschek,20
Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy,https://journals.sagepub.com/doi/abs/10.1177/0284185116658322,"A Saracco, BK Szabó, E Tánczos, J Bergh… ","Acta …, 2017 ","Background One of the big challenges in onco-radiology is to find a reliable imaging method 
that may predict early response during the first cycles of any neoadjuvant chemotherapy. 
Purpose To evaluate the use of real-time harmonic contrast-enhanced ultrasound (CEUS) in …",Thomas Hatschek,20
[HTML][HTML] Immune gene expression and response to chemotherapy in advanced breast cancer,https://www.nature.com/articles/bjc2017446,"T Foukakis, J Lövrot, A Matikas, I Zerdes… ","British journal of …, 2018 ","Background: Transcriptomic profiles have shown promise as predictors of response to 
neoadjuvant chemotherapy in breast cancer (BC). This study aimed to explore their predictive 
value in the advanced BC (ABC) setting. Methods: In a Phase 3 trial of first-line chemotherapy in …",Thomas Hatschek,30
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast …,https://clincancerres.aacrjournals.org/content/22/1/146.short,"S Kimbung, I Johansson, A Danielsson, S Veerla… ","Clinical cancer …, 2016 ","Purpose: The complete molecular basis of the organ-specificity of metastasis is elusive. This 
study aimed to provide an independent characterization of the transcriptional landscape of 
breast cancer metastases with the specific objective to identify liver metastasis–selective …",Thomas Hatschek,30
"Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX …",https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.501,"JCS Bergh, A Andersson, J Bjohle, A Bosch… ",2019 ,"501 Background: Neoadjuvant therapy produces high rates of pathological complete response 
(pCR) and is the standard of care in HER2 positive breast cancer; however, the optimal 
treatment regimen remains to be established. Methods: In this randomized phase II study …",Thomas Hatschek,30
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen,https://www.tandfonline.com/doi/abs/10.1080/0284186X.2016.1273547,"J Rosell, B Nordenskjöld, NO Bengtsson… ","Acta …, 2017 ","Background: Tamoxifen is a well established treatment for breast cancer, but its long-term 
effects on the incidence of secondary cancers are not fully evaluated. Material and methods: 
We have studied 4128 postmenopausal patients with early stage breast cancer who were …",Thomas Hatschek,30
[HTML][HTML] Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer,https://link.springer.com/article/10.1007/s10549-017-4164-1,"LH Zetterlund, J Frisell, A Zouzos, R Axelsson… ","Breast cancer research …, 2017 ","Purpose Patients with clinically node-positive breast cancer planned for neoadjuvant systemic 
therapy (NAST) may draw advantages from the nodal downstaging effect and reduce the 
extent of axillary surgery with sentinel lymph node biopsy (SLNB) performed after NAST. …",Thomas Hatschek,30
[HTML][HTML] Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family …,https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4021-6,"U Kjällquist, R Erlandsson, NP Tobin… ","BMC …, 2018 ","Tumor heterogeneity in breast cancer tumors is today widely recognized. Most of the available 
knowledge in genetic variation however, relates to the primary tumor while metastatic 
lesions are much less studied. Many studies have revealed marked alterations of standard …",Thomas Hatschek,30
Protein profiling of fine‐needle aspirates reveals subtype‐associated immune signatures and involvement of chemokines in breast cancer,https://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12410,"B Franzén, A Alexeyenko… ","Molecular …, 2019 ","There are increasing demands for informative cancer biomarkers, accessible via minimally 
invasive procedures, both for initial diagnostics and for follow‐up of personalized cancer 
therapy, including immunotherapy. Fine‐needle aspiration ( FNA ) biopsy provides ready access …",Thomas Hatschek,30
"Occupational risks of thyroid cancer: Data from the swedish cancer‐environment register, 1961‐1979",https://onlinelibrary.wiley.com/doi/abs/10.1002/ajim.4700180503,"JM Carstensen, G Wingren, T Hatschek… ","American journal of …, 1990 ","Using data from a record‐linkage between the Swedish population census of 1960 and the 
Swedish Cancer Registry, we performed an explorative, hypothesis‐generating analysis of 
the incidence of thyroid cancer in 208 occupations and 231 industries. Relative risks were …",Thomas Hatschek,30
"Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 …",https://www.tandfonline.com/doi/abs/10.1080/2162402X.2018.1466017,"A Matikas, J Lövrot, A Ramberg, M Eriksson… ","…, 2018 ","Gene expression (GE) signatures and Tumor Infiltrating Lymphocytes (TIL) enumeration are 
predictive for response to neoadjuvant chemotherapy in HR- and in HER2+ breast cancer, 
but data are conflicting in HR+/HER2- disease. This study aimed to explore their predictive …",Thomas Hatschek,30
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer–A national survey performed at pathology departments in Sweden,https://www.tandfonline.com/doi/abs/10.1080/02841860902862511,"L Rydén, M Haglund, PO Bendahl, T Hatschek… ","Acta …, 2009 ","Background. HER2 is a treatment predictive factor for the effect of trastuzumab and associated 
with poor prognosis in breast cancer. The analysis of HER2 must be performed with good 
quality, with regard to both the immunohistochemical (IHC) and in situ hybridization (ISH) …",Thomas Hatschek,30
"[HTML][HTML] Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden",https://link.springer.com/article/10.1007/s10549-011-1594-z,"T Foukakis, T Fornander, T Lekberg, H Hellborg… ","Breast cancer research …, 2011 ","Abstract Treatment of metastatic breast cancer (MBC) has evolved during the last decades but 
it is largely unknown whether this has led to improved survival in the general MBC population. 
Based on the regional, population-based breast cancer registry, we identified 5,463 …",Tobias Lekberg,10
[HTML][HTML] First results of the preoperative accelerated partial breast irradiation (PAPBI) trial,https://www.sciencedirect.com/science/article/pii/S0167814015000778,"F Van Der Leij, SCJ Bosma, MJ Van De Vijver… ","Radiotherapy and …, 2015 ","Background and purpose The aim of this study is to assess the toxicity and cosmetic outcome 
of preoperative accelerated partial breast irradiation (PAPBI) for breast cancer patients with 
low risk on local recurrence. Material and methods Women aged ⩾60 years with an invasive…",Tobias Lekberg,10
Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus …,https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31070,"S Kimbung, I Markholm, J Bjöhle… ","… journal of cancer, 2018 ","Pathologic complete response (pCR) is a predictor for favorable outcome after neoadjuvant 
treatment in early breast cancer. Modulation of gene expression may also provide early 
readouts of biological activity and prognosis, offering the possibility for timely response‐guided …",Tobias Lekberg,10
"Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer: a phase 2 randomized clinical trial",https://jamanetwork.com/journals/jamaoncology/article-abstract/2781086,"T Hatschek, T Foukakis, J Bjöhle, T Lekberg… ","JAMA …, 2021 ","Importance Trastuzumab emtansine (T-DM1) is presently approved for treatment of advanced 
breast cancer and after incomplete response to neoadjuvant therapy, but the potential of 
T-DM1 as monotherapy is so far unknown. Objective To assess pathologic complete response …",Tobias Lekberg,10
[HTML][HTML] The impact of a hepatobiliary multidisciplinary team assessment in patients with colorectal cancer liver metastases: a population‐based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599196/,"J Engstrand, N Kartalis, C Strömberg, M Broberg… ","The …, 2017 ","Background. Assessing patients with colorectal cancer liver metastases (CRCLM) by a liver 
multidisciplinary team (MDT) results in higher resection rates and improved survival. The aim 
of this study was to evaluate the potentially improved resection rate in a defined cohort if all …",Tobias Lekberg,10
"Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX …",https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.501,"JCS Bergh, A Andersson, J Bjohle, A Bosch… ",2019 ,"501 Background: Neoadjuvant therapy produces high rates of pathological complete response 
(pCR) and is the standard of care in HER2 positive breast cancer; however, the optimal 
treatment regimen remains to be established. Methods: In this randomized phase II study …",Tobias Lekberg,10
Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial,https://www.sciencedirect.com/science/article/pii/S036030162030050X,"SCJ Bosma, F Leij, S Vreeswijk, M de Maaker… ","International Journal of …, 2020 ","Purpose In this multicenter phase 2 feasibility study, we investigated the impact of 
preoperative accelerated partial breast irradiation (PAPBI) on local control, breast fibrosis, and 
cosmetic outcome. Methods and Materials Women aged >60 years with an invasive, unifocal (…",Tobias Lekberg,10
"Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 …",https://www.tandfonline.com/doi/abs/10.1080/2162402X.2018.1466017,"A Matikas, J Lövrot, A Ramberg, M Eriksson… ","…, 2018 ","Gene expression (GE) signatures and Tumor Infiltrating Lymphocytes (TIL) enumeration are 
predictive for response to neoadjuvant chemotherapy in HR- and in HER2+ breast cancer, 
but data are conflicting in HR+/HER2- disease. This study aimed to explore their predictive …",Tobias Lekberg,10
"Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant …",https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.583,"Y Brandberg, A Andersson, J Bjohle, A Bosch… ",2019 ,"583 Background: Neoadjuvant therapy combining docetaxel, trastuzumab and pertuzumab (DTP) 
was compared to trastuzumab emtansine (T-DM1) in the randomized phase 2 PREDIX 
HER2 trial. Patients, ≥18 years with HER2 positive breast cancer, ≥20mm or with verified …",Tobias Lekberg,10
"One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab …",https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.590,"Y Brandberg, T Foukakis, A Andersson, J Bjohle… ",2020 ,"590 Background: Neoadjuvant therapy combining docetaxel, trastuzumab and pertuzumab (DTP) 
was compared to trastuzumab emtansine (T-DM1) in the randomised phase II PREDIX 
HER2 trial. Patients, ≥18 years with HER2 positive breast cancer, ≥20mm or with verified …",Tobias Lekberg,10
Abstract P3-11-14: Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer? Clinical results from a neoadjuvant trial using a …,https://cancerres.aacrjournals.org/content/75/9_Supplement/P3-11-14.short,"T Hatschek, J Bjöhle, E Lidbrink, T Lekberg, N Loman… ",2015 ,"Background: Several randomized trials have proven that preoperative chemotherapy is 
equivalent to adjuvant treatment, and allows for clinical and radiological assessment of efficacy 
in vivo. Recent results show that response-guided neoadjuvant therapy is a favorable policy …",Tobias Lekberg,20
"Abstract P2-05-02: Preliminary translational results from PROMIX, a phase II trial of preoperative chemotherapy with the addition of bevacizumab in large operable …",https://cancerres.aacrjournals.org/content/75/9_Supplement/P2-05-02.short,"N Loman, I Johansson, J Bjöhle, J Frisell, T Lekberg… ",2015 ,"Background: Preoperative chemotherapy in breast cancer (bc) provides unique possibilities to 
evaluate effects of therapy by studying response and changes in the tumor during the course 
of treatment. A pathologic complete response (pCR) correlates positively with long term …",Tobias Lekberg,20
[CITATION][C] Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer?: Clinical results from a neoadjuvant trial using a …,https://www.diva-portal.org/smash/record.jsf?pid=diva2:843706,"T Hatschek, J Bjoehle, E Lidbrink, T Lekberg… ","Cancer …, 2015 ",,Tobias Lekberg,20
[CITATION][C] Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer?: Clinical results from a neoadjuvant trial using a …,https://www.diva-portal.org/smash/record.jsf?pid=diva2:843706,"T Hatschek, J Bjoehle, E Lidbrink, T Lekberg… ","Cancer …, 2015 ",,Tobias Lekberg,20
"He Huang, MD Yan-Ling Feng, MD",https://jamanetwork.com/journals/jamaoncology/article-abstract/2783010,JH Liu ,"JAMA, 2021 ","1. Huang H, Feng YL, Wan T, et al. Effectiveness of sequential chemoradiation vs concurrent 
chemoradiation or radiation alone in adjuvant treatment after hysterectomy for cervical 
cancer: the STARS phase 3 randomized clinical trial. JAMA Oncol. 2021; 7 (3): 361-369. doi: …",Tobias Lekberg,20
Bevacizumab treatment of patients with breast cancer is associated with induction of MYLK.,https://osf.io/preprints/tcnpf/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,20
Bevacizumab treatment of patients with breast cancer is associated with differential expression and up-regulation of C10orf10.,https://osf.io/preprints/w8yc5/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,20
Bevacizumab treatment of patients with breast cancer is associated with differential expression and up-regulation of hepatic leukemia factor (HLF).,https://osf.io/preprints/hwq3p/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,20
Bevacizumab treatment of patients with breast cancer is associated with induction of SOX17.,https://osf.io/preprints/d4u2h/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,20
Bevacizumab treatment of patients with breast cancer is associated with differential expression and up-regulation of TIPARP.,https://osf.io/preprints/we8f9/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,20
"Bevacizumab treatment of patients with breast cancer is associated with differential expression and up-regulation of the thyrotroph embryonic factor, TEF.",https://osf.io/preprints/twnau/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,30
"Bevacizumab treatment of patients with breast cancer results in induction of KLF2, KLF4, KLF6 and KLF9.",https://osf.io/preprints/r46ey/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,30
[PDF][PDF] Bevacizumab treatment of patients with breast cancer is associated with differential expression and up-regulation of the leukemia inhibitory factor receptor (LIFR …,https://osf.io/zb6dm/download,S Mamoor ,osf.io,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency1 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials in …",Tobias Lekberg,30
Bevacizumab treatment nullifies Bax up-regulation induced by epirubicin and docetaxel chemotherapy in human breast cancer.,https://osf.io/preprints/zawuv/,S Mamoor ,2020 ,"Chemotherapeutics utilized in breast cancer, including taxane drugs such as docetaxel, exert 
their function through a variety of mechanisms; one of these is the induction of apoptotic 
genes (1) like those of the Bcl-2 family (2). We found through mining published data from the …",Tobias Lekberg,30
Bevacizumab treatment of patients with breast cancer is associated with induction of AP-1 transcription factor subunits.,https://osf.io/preprints/hbn5m/,S Mamoor ,2020 ,"Bevacizumab (Avastin) is an approved treatment option by the European Medicines Agency (1) 
for more than a quarter billion women in the European Union, and despite having its indication 
withdrawn by the Food and Drug Administration in 2011 is still utilized in clinical trials …",Tobias Lekberg,30
Bevacizumab treatment phenocopies changes in MMP11 expression found in the brain metastases of patients with brain cancer.,https://osf.io/preprints/un9ez/,S Mamoor ,2020 ,"Brain metastases in patients with brain cancer is a clinical problem (1-3). Bevacizumab, a 
monoclonal antibody targeting the vascular endothelial growth factor A (VEGF-A), is utilized 
in patients with metastatic breast cancer with no effect on overall survival while prolonging …",Tobias Lekberg,30
[PDF][PDF] Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour …,https://link.springer.com/content/pdf/10.1186/s12885-020-06925-y.pdf,B Tribukait ,"BMC cancer, 2020 ","Background After neoadjuvant chemotherapy of breast cancer pathologic complete response 
(pCR) indicates a favorable prognosis. Among non-selected patients, pCR is, however, 
achieved in only 10–30%. Early evaluation of tumour response to treatment would facilitate …",Tobias Lekberg,30
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States,https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.29348,"SS Mougalian, PR Soulos, BK Killelea, DR Lannin… ","Cancer, 2015 ","BACKGROUND Neoadjuvant chemotherapy (NAC) is the standard of care for patients with 
locally advanced breast cancer and can yield clinical advantages in individuals with lower 
stage cancers as well. To the authors' knowledge, the extent and patterns of use of NAC remain …",Tobias Lekberg,30
[HTML][HTML] 1st International consensus guidelines for advanced breast cancer (ABC 1),https://www.sciencedirect.com/science/article/pii/S0960977612000628,"F Cardoso, A Costa, L Norton, D Cameron, T Cufer… ","The Breast, 2012 ","The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place 
on November 2011, in Lisbon. Consensus guidelines for the management of this disease 
were developed. This manuscript summarizes these international consensus guidelines. …",Tobias Lekberg,30
Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer,https://www.mdpi.com/2072-6694/13/21/5442,B Tribukait ,"Cancers, 2021 ","Simple Summary Chemotherapy before surgery (NAC) is an option for high-risk breast 
cancer (BC) patients. Pathologic complete response (pCR) predicts long-term outcome and 
has become a surrogate biomarker for survival. pCR is, however, reached in only <10% of …",Tobias Lekberg,30
[HTML][HTML] Adjuvant docetaxel for node-positive breast cancer,https://www.nejm.org/doi/full/10.1056/nejmoa043681,"M Martin, T Pienkowski, J Mackey… ","… England Journal of …, 2005 ","Background We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with 
fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for 
operable node-positive breast cancer. Methods We randomly assigned 1491 women with …",Tommy Fornander,10
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers,https://www.sciencedirect.com/science/article/pii/S0140673689911410,"T Fornander, B Cedermark, A Mattsson, L Skoog… ","The Lancet, 1989 ","The frequency of new primary cancers was studied in 1846 postmenopausal patients included 
in a randomised trial of tamoxifen as an adjunct to primary surgery for early breast cancer. 
The median follow-up was 4·5 years (range 0·5-10·5 years). The number of new cancers in …",Tommy Fornander,10
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies,https://academic.oup.com/jnci/article-abstract/87/9/645/907911,"LE Rutqvist, H Johansson, T Signomklao… ","JNCI: Journal of the …, 1995 ","Background: Tamoxifen is being increasingly used for the treatment of breast cancer and is 
undergoing study for the primary prevention of breast cancer. However, concerns have 
been raised that the drug may increase the incidence of new primary malignancies, such as …",Tommy Fornander,10
Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer,https://www.sciencedirect.com/science/article/pii/036030169290784F,"LE Rutqvist, I Lax, T Fornander, H Johansson ","International Journal of …, 1992 ","One concern with adjuvant radiation therapy for early breast cancer is the potential risk of 
increasing intercurrent mortality due to radiation-induced damage of the myocardium. The 
paper presents an analysis of long-term survival among 960 patients with primary breast cancer …",Tommy Fornander,10
"[HTML][HTML] Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden",https://www.sciencedirect.com/science/article/pii/S0167814011003276,"P McGale, SC Darby, P Hall, J Adolfsson… ","Radiotherapy and …, 2011 ","Purpose To study incidence of radiation-related heart disease in a large population of breast 
cancer patients followed for up to 30 years. Material and methods 72,134 women diagnosed 
with breast cancer in Denmark or Sweden during 1976–2006 and followed prospectively. …",Tommy Fornander,10
Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients,https://www.sciencedirect.com/science/article/pii/027753799190295O,"G Berglund, C Bolund, T Fornander, LE Rutqvist… ","European Journal of …, 1991 ","Late effects of adjuvant treatment on perceived health and quality of life were assessed 
through a questionnaire mailed to 448 premenopausal and postmenopausal breast cancer 
patients, free from recurrence 2–10 years after primary therapy. The patients had been …",Tommy Fornander,10
[HTML][HTML] Long-term cardiac morbidity and mortality in a randomized trial of pre-and postoperative radiation therapy versus surgery alone in primary breast cancer,https://www.sciencedirect.com/science/article/pii/S0167814098000620,"G Gyenes, LE Rutqvist, A Liedberg… ","Radiotherapy and …, 1998 ","Background and purpose: Some types of radiation therapy have been associated with an 
increased risk of cardiac mortality and morbidity in patients with early-stage breast cancer. A 
relationship has been observed between cardiac radiation dose-volume and the level of …",Tommy Fornander,10
"[HTML][HTML] Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial",https://www.sciencedirect.com/science/article/pii/S1470204512705259,"JR Mackey, M Martin, T Pienkowski, J Rolski… ","The Lancet …, 2013 ","Background We compared standard adjuvant anthracycline chemotherapy with 
anthracycline–taxane combination chemotherapy in women with operable node-positive breast 
cancer. Here we report the final, 10-year follow-up analysis of disease-free survival, overall survival, …",Tommy Fornander,10
Breast cancer index identifies early-stage estrogen receptor–positive breast cancer patients at risk for early-and late-distant recurrence,https://clincancerres.aacrjournals.org/content/19/15/4196.short,"Y Zhang, CA Schnabel, BE Schroeder, PL Jerevall… ","Clinical Cancer …, 2013 ","Purpose: Residual risk of relapse remains a substantial concern for patients with hormone 
receptor–positive breast cancer, with approximately half of all disease recurrences occurring 
after five years of adjuvant antiestrogen therapy. Experimental Design: The objective of this …",Tommy Fornander,10
[HTML][HTML] Prognostic utility of HOXB13: IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial,https://www.nature.com/articles/bjc2011145,"PL Jerevall, XJ Ma, H Li, R Salunga, NC Kesty… ","British journal of …, 2011 ","Background: A dichotomous index combining two gene expression assays, HOXB13: 
IL17BR (H: I) and molecular grade index (MGI), was developed to assess risk of recurrence 
in breast cancer patients. The study objective was to demonstrate the prognostic utility of the …",Tommy Fornander,10
Predictors of return to work ten months after primary breast cancer surgery,https://www.tandfonline.com/doi/abs/10.1080/02841860802477899,"A Johnsson, T Fornander, LE Rutqvist, M Vaez… ","Acta …, 2009 ","Background. The most common female cancer in Western countries is breast cancer and 
women diagnosed with this disease are often under 65 years old. With increasing prevalence 
of survivors it is important to shed light on problems facing these women after diagnosis and …",Tommy Fornander,20
"[HTML][HTML] Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose",https://link.springer.com/article/10.1023/A:1012292019599,"PARM Lind, B Wennberg, G Gagliardi… ","Breast cancer research …, 2001 ","Purpose. This study investigates the incidence of short-term pulmonary complications 
following radiotherapy (RT) for breast cancer (BC) with different treatment techniques/incidentally 
irradiated lung volumes and the importance of confounding factors on RT-induced pulmonary …",Tommy Fornander,20
Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy.,https://ascopubs.org/doi/abs/10.1200/JCO.1997.15.4.1348,"G Gyenes, G Gagliardi, I Lax, T Fornander… ","Journal of clinical …, 1997 ","PURPOSE To quantify the proportion of heart volumes that received at least 25 Gy with 
tangential photon fields in patients with left-sided stage I (T1 NOMO) breast cancer treated 
with breast-conserving surgery. METHODS AND MATERIALS The dose planning of 100 …",Tommy Fornander,20
Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study,https://www.sciencedirect.com/science/article/pii/S0360301696001253,"G Gyenes, T Fornander, P Carlens, U Glas… ","International Journal of …, 1996 ","Purpose : To look for early and late signs of cardiac side effects of postoperative radiotherapy 
in patients with left-sided breast cancer. Methods and Materials : Seventeen left-sided 
primary (Stage I–III) breast cancer patients considered eligible were recruited. Their computer …",Tommy Fornander,20
Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy,https://www.sciencedirect.com/science/article/pii/0360301694905002,"G Gyenes, T Fornander, P Carlens… ","International Journal of …, 1994 ","Purpose : To assess the cardiac side effects, primarily the occurrence of ischemic heart 
disease in symptom-free patients with early breast cancer treated with radiotherapy. Methods 
and Materials : Thirty-seven survivors of a former randomized study of early breast cancer were …",Tommy Fornander,20
[HTML][HTML] Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial,https://www.sciencedirect.com/science/article/pii/S0959804912005497,"M Fahlén, T Fornander, H Johansson… ","European journal of …, 2013 ","Background The management of hormonal deficiency symptoms in breast cancer survivors 
is an unsolved problem. While hormone replacement therapy (HRT) may increase the risk of 
breast cancer in healthy women, its effects on recurrence is unclear. Observational studies …",Tommy Fornander,20
"[HTML][HTML] Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit",https://link.springer.com/article/10.1007/s10549-012-2376-y,"J Bostner, E Karlsson, MJ Pandiyan… ","Breast cancer research …, 2013 ","The frequent alterations of the PI3K/Akt/mTOR-growth signaling pathway are proposed 
mechanisms for resistance to endocrine therapy in breast cancer, partly through regulation of 
estrogen receptor α (ER) activity. Reliable biomarkers for treatment prediction are required for …",Tommy Fornander,20
[HTML][HTML] Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study,https://link.springer.com/article/10.1007/s10549-012-1961-4,"A Wigertz, J Ahlgren, M Holmqvist, T Fornander… ","Breast cancer research …, 2012 ","Adherence to long-term pharmacological treatment for chronic conditions is often less than 
optimal. Till date, a limited number of population-based studies have assessed adherence 
to adjuvant hormonal therapy in breast cancer, a therapy with proven benefits in terms of …",Tommy Fornander,20
Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity,https://www.spandidos-publications.com/10.3892/or.14.4.1013,"Q He, P Zhang, L Zou, H Li, X Wang… ","Oncology …, 2005 ","Activity of thymidine kinase 1 in serum (STK) is a useful marker for leukaemia and lymphoma, 
but not for solid tumors. We investigate thymidine kinase 1 concentration in serum (S-TK1) 
as a potential tumor marker. S-TK1 concentration and STK activity levels were determined in …",Tommy Fornander,20
Factors associated with return to work after breast cancer treatment,https://www.tandfonline.com/doi/abs/10.1080/02841860600857318,"A Johnsson, T Fornander, M Olsson, M Nystedt… ","Acta …, 2007 ","Relatively few studies have addressed problems regarding return to work after primary treatment 
for early-stage breast cancer. The purpose of this study was to investigate whether 
socio-economic and treatment-related factors were associated with problems of returning to work …",Tommy Fornander,20
Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study,https://ascopubs.org/doi/abs/10.1200/JCO.2003.04.024,"M Nystedt, G Berglund, C Bolund… ","Journal of clinical …, 2003 ","Purpose: To compare the effect of adjuvant endocrine therapies with and without chemotherapy 
on physical symptoms, anxiety, and depressive symptoms in premenopausal women with 
breast cancer in a randomized clinical trial (the Zoladex in Premenopausal Patients trial). …",Tommy Fornander,30
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer,https://academic.oup.com/jnci/article-abstract/85/22/1850/962746,"T Fornander, AC Hellström… ","JNCI: Journal of the …, 1993 ","Background: Studies have shown that patients with early-stage endometrial cancer who have 
previously used endogenous estrogen (oral contraceptives or estrogen replacement therapy) 
have a favorable prognosis. This has not yet been demonstrated for patients with early-…",Tommy Fornander,30
Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer,https://ar.iiarjournals.org/content/26/6C/4753.short,"Q He, T Fornander, H Johansson… ","Anticancer …, 2006 ","Background: The prognostic value of the concentration of serum thymidine kinase 1 (S-TK1) 
with regard to recurrence in low risk breast cancer patients, 3 months after surgery was 
evaluated. Patients and Methods: The concentration of S-TK1 in serum was determined in 120 …",Tommy Fornander,30
Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer,https://academic.oup.com/jnci/article-abstract/101/5/341/912161,"A Hackshaw, M Baum, T Fornander… ","Journal of the …, 2009 ","Background Systematic reviews have found that luteinizing hormone–releasing hormone (LHRH) 
agonists are effective in treating premenopausal women with early breast cancer. Methods 
We conducted long-term follow-up (median 12 years) of 2706 women in the Zoladex In …",Tommy Fornander,30
"[HTML][HTML] The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a …",https://link.springer.com/article/10.1186/bcr3557,"E Karlsson, G Pérez-Tenorio, R Amin, J Bostner… ","Breast Cancer …, 2013 ","mTOR and its downstream effectors the 4E-binding protein 1 (4EBP1) and the p70 ribosomal 
S6 kinases (S6K1 and S6K2) are frequently upregulated in breast cancer, and assumed 
to be driving forces in tumourigenesis, in close connection with oestrogen receptor (ER) …",Tommy Fornander,30
"[HTML][HTML] Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden",https://link.springer.com/article/10.1007/s10549-011-1594-z,"T Foukakis, T Fornander, T Lekberg, H Hellborg… ","Breast cancer research …, 2011 ","Abstract Treatment of metastatic breast cancer (MBC) has evolved during the last decades but 
it is largely unknown whether this has led to improved survival in the general MBC population. 
Based on the regional, population-based breast cancer registry, we identified 5,463 …",Tommy Fornander,30
[HTML][HTML] Impact of comorbidity on management and mortality in women diagnosed with breast cancer,https://link.springer.com/article/10.1007/s10549-012-2176-4,"A Berglund, A Wigertz, J Adolfsson, J Ahlgren… ","Breast cancer research …, 2012 ","To investigate associations between comorbidity burden, management, and mortality in women 
with breast cancer. A total of 42,646 women diagnosed with breast cancer between 1992 
and 2008 were identified in two Clinical Quality Registers in Central Sweden. Breast cancer-…",Tommy Fornander,30
Work status and life changes in the first year after breast cancer diagnosis,https://content.iospress.com/articles/work/wor01137,"A Johnsson, T Fornander, LE Rutqvist, M Olsson ","Work, 2011 ","Objective: The aims of this study were to generate new knowledge about factors predicting 
return to work (RTW) among women treated for early-stage breast cancer, and about changes 
in life satisfaction, and coping, and to examine the association between these concepts and …",Tommy Fornander,30
Effect of tailored dose-dense chemotherapy vs standard 3-weekly adjuvant chemotherapy on recurrence-free survival among women with high-risk early breast cancer …,https://jamanetwork.com/journals/jama/article-abstract/2579866,"T Foukakis, G Von Minckwitz, NO Bengtsson… ","Jama, 2016 ","Importance Standard dosing of chemotherapy based on body surface area results in marked 
interpatient variation in pharmacokinetics, toxic effects, and efficacy. Whether tailored dosing 
can improve outcomes is unknown, as is the role of dose-dense adjuvant chemotherapy. …",Tommy Fornander,30
Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades,https://jamanetwork.com/journals/jamaoncology/article-abstract/2634502,"LJ Esserman, C Yau, CK Thompson… ","JAMA …, 2017 ","Importance The frequency of cancers with indolent behavior has increased with screening. 
Better tools to identify indolent tumors are needed to avoid overtreatment. Objective To 
determine if a multigene classifier is associated with indolent behavior of invasive breast cancers …",Tommy Fornander,30
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast—long-term prognostic significance,https://www.mdpi.com/772140,"U Narbe, PO Bendahl, K Aaltonen, M Fernö, C Forsare… ","Cells, 2020 ","Background: Invasive lobular carcinoma (ILC) has distinguishing features when compared to 
invasive ductal carcinoma of no special type (NST). In this study, we explored the distributional 
and prognostic characteristics of circulating tumor cells (CTCs) in metastatic ILC and NST…",Ulrik Narbe,10
"[HTML][HTML] Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor",https://link.springer.com/article/10.1186/2193-1801-3-70,"U Narbe, PO Bendahl, D Grabau, L Rydén, C Ingvar… ","Springerplus, 2014 ","The aim of the present study was to investigate the long-term impact of prognostic factors in 
invasive lobular carcinoma (ILC) of the breast, with a primary focus on Ki67 and histological 
grade, alone and in combination with estrogen receptor (ER). One hundred and ninety two …",Ulrik Narbe,10
[HTML][HTML] The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast,https://link.springer.com/article/10.1007/s10549-019-05138-7,"U Narbe, M Sjöström, C Forsare, PO Bendahl… ","Breast cancer research …, 2019 ","Purpose According to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, 
progesterone receptor (PR) and Nottingham histological grade (NHG) are used for prognostic 
classification of estrogen receptor (ER) positive/HER2-negative breast cancer into luminal …",Ulrik Narbe,10
[HTML][HTML] The St. Gallen 2019 Guidelines understages the Axilla in Lobular Breast Cancer–a Population-Based Study,https://www.medrxiv.org/content/10.1101/2021.06.08.21258532v1.full-text,"U Narbe, PO Bendahl, M Fernö, C Ingvar, L Dihge… ","medRxiv, 2021 ","Background The St. Gallen 2019 guidelines recommend omission of completion axillary lymph 
node dissection (cALND) in breast cancer patients with 1-2 sentinel lymph node (SLN) 
metastases regardless of histopathology. Concurrently, adjuvant chemotherapy is endorsed for …",Ulrik Narbe,10
[PDF][PDF] Prognostic Factors and Metastatic Routes in Lobular Breast Cancer. Same Same but Different.,https://portal.research.lu.se/portal/files/86533602/Ulrik_Narbe_web.pdf,U Narbe ,2020 ,"Invasive lobular carcinoma (ILC) is the second most common histopathological type of breast 
cancer (~ 10%) after invasive ductal carcinoma of no special type (NST)(~ 80%). Compared 
with NST, ILC has distinguishing clinicopathological and genomic features, and its …",Ulrik Narbe,10
Abstract P4-01-04: The distribution and prognostic significance of circulating tumor cells are different in invasive lobular carcinoma compared to invasive ductal …,https://cancerres.aacrjournals.org/content/80/4_Supplement/P4-01-04.short,"UC Narbe, PO Bendahl, K Aaltonen, M Fernö… ",2020 ,"Background: Circulating tumor cells (CTCs) have repeatedly been shown to carry independent 
prognostic information in metastatic breast cancer (MBC). A CTC count of 5 cells per 7.5 
mL blood is a generally accepted cut-off, where MBCs with <5 CTCs are classified as MBC …",Ulrik Narbe,10
[CITATION][C] 137 Ki-67 as a long-term prognostic factor in lobular breast cancer,https://www.infona.pl/resource/bwmeta1.element.elsevier-8a4a331d-e899-3884-b24b-632fa8d544ef,"U Narbe, PO Bendahl, D Grabau, L Rydén, M Fernö… ","EJC Supplements, 2010 ","137 Ki-67 as a long-term prognostic factor in lobular breast cancer × Close The Infona portal 
uses cookies, ie strings of text saved by a browser on the user's device. The portal can access 
those files and use them to remember the user's data, such as their chosen settings (screen …",Ulrik Narbe,10
The role of sonoelastography for a better characterization of infiltrating lobular carcinoma,https://epos.myesr.org/esr/viewing/index.php?module=viewing_poster&pi=126767,"RM Sgarbura, AI Ciurea ",2015 ,"Background ILC is the second most common histological type of breast cancer, accounting 
for approximately 10%–15% of all invasive breast cancers [1]. Compared with the more 
common invasive ductal carcinoma (IDC), ILC has different etiological, clinical and biological …",Ulrik Narbe,10
The role of sonoelastography for a better characterization of infiltrating lobular carcinoma,https://epos.myesr.org/esr/viewing/index.php?module=viewing_poster&pi=126767,"RM Sgarbura, AI Ciurea ",2015 ,"Background ILC is the second most common histological type of breast cancer, accounting 
for approximately 10%–15% of all invasive breast cancers [1]. Compared with the more 
common invasive ductal carcinoma (IDC), ILC has different etiological, clinical and biological …",Ulrik Narbe,10
Weekly paclitaxel—still preferred first-line taxane for mBC,https://www.nature.com/articles/nrclinonc.2015.137,"J Gligorov, S Richard ","Nature Reviews Clinical Oncology, 2015 ","Refers to Rugo, HS et al. Randomized phase III trial of paclitaxel once per week compared with 
nanoparticle albumin-bound nabpaclitaxel once per week or ixabepilone with bevacizumab 
as first-line chemotherapy for locally recurrent or metastatic breast cancer: CALGB 40502/…",Ulrik Narbe,10
Androgen receptors frequently are expressed in breast carcinomas: Potential relevance to new therapeutic strategies,https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.11532,"F Moinfar, M Okcu, O Tsybrovskyy… ","… Journal of the …, 2003 ","BACKGROUND Several studies have demonstrated the biologic and therapeutic significance 
of estrogen and progesterone receptors (ER and PR) in breast carcinomas. The aim of the 
current study was to examine the presence of androgen receptors (AR) in breast carcinomas…",Ulrik Narbe,19
[PDF][PDF] Bröstcancerprocessen i region Kronoberg före och efter införandet av standardiserat vårdförlopp,https://www.diva-portal.org/smash/get/diva2:974607/FULLTEXT01.pdf,E Myrskog ,2016 ,"… Först och främst vill jag rikta ett stort tack till min handledare Ulrik Narbe, överläkare på 
Onkologkliniken vid Centrallasarettet Växjö. Stort tack också till överläkare Lena Myrskog på 
Kirurgkliniken vid Centrallasarettet Växjö som har hjälpt till med att ta fram all information om …",Ulrik Narbe,19
[HTML][HTML] Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast …,https://www.sciencedirect.com/science/article/pii/S0923753419311615,"T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi… ","Annals of …, 2019 ","Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line 
therapy for HER2-positive metastatic breast cancer, based on results from the phase III 
CLEOPATRA trial. PERUSE was designed to assess the safety and efficacy of investigator-…",Ulrik Narbe,19
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells,https://www.mdpi.com/696328,"C Forsare, PO Bendahl, E Moberg… ","International journal of …, 2020 ","… We thank Ulrik Narbe for providing the follow-up data. This work was supported by 
BioCare–Strategic Research Area at Lund University (2016-124359), The Swedish Cancer Society 
(2016/563; 190388), the Mrs Berta Kamprad Foundation (2017-39), the Crafoord Foundation (…",Ulrik Narbe,19
"[HTML][HTML] EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of …",https://www.nature.com/articles/bjc201380,"SD Soysal, S Muenst, T Barbie, T Fleming… ","British journal of …, 2013 ","Background: Epithelial cell adhesion molecule (EpCAM) is frequently expressed in breast 
cancer, and its expression has been associated with poor prognosis. Breast cancer can be 
subdivided into intrinsic subtypes, differing in prognosis and response to therapy. Methods: To …",Ulrik Narbe,19
Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution,https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.23811,"E Orvieto, E Maiorano, L Bottiglieri… ","… Journal of the …, 2008 ","BACKGROUND. Although invasive lobular carcinoma (ILC) is the second most common 
histotype of breast cancer, the prognostic implications of its clinicopathologic characteristics 
remain controversial. METHODS. The authors undertook a retrospective analysis of a large …",Ulrik Narbe,19
[HTML][HTML] Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes,https://www.nature.com/articles/bjc2013743,"DJE Peeters, PJ Van Dam… ","British journal of …, 2014 ","Background: The enumeration of circulating tumour cells (CTCs) with the EpCAM-based 
CellSearch system has prognostic significance in patients with metastatic breast cancer (MBC). 
The aim of this study was to explore potential differences in the detection and prognostic …",Ulrik Narbe,19
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications,https://www.mdpi.com/2072-6694/13/7/1592,"CLT Jørgensen, AM Larsson, C Forsare, K Aaltonen… ","Cancers, 2021 ","… The authors thank Sara Baker for professional construction of the study database and Ulrik 
Narbe for providing follow-up data. The authors thank Biobank Syd for excellent service with 
the retrieval of FFPE tissue, clinical pathologist Anna Ehinger for pathology consultancy, and …",Ulrik Narbe,19
[BOOK][B] High-throughput molecular techniques and personalized treatment for primary breast cancer,https://portal.research.lu.se/portal/files/35860727/Martin_Sj_str_m_Kappa.pdf,M Sjöström ,2018 ,"Breast cancer is the most common cancer among women worldwide. The heterogeneity 
between tumors is the basis for precision medicine. Better characterization of tumors, 
leading to clinical decision tools, is needed to further individualize therapy, and to avoid over-treatment …",Ulrik Narbe,19
,,,,,Ulrik Narbe,19
[PDF][PDF] Randomized Multicentre Phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in primary high risk …,https://dccg.nl/files/RAPIDO_protocol_version3.2_final_20190904_signed.pdf,"L Blomqvist, JC Beukema, B van Etten, B Glimelius… ",dccg.nl,"Steering committee: R. Beets-Tan, radiology, NKI-AvL-Amsterdam JC Beukema, 
radiotherapy, UMC Groningen L. Blomqvist, radiology, Karolinska UH, Stockholm A. Cats, 
gastro-enterology, NKI-AVL-Amsterdam B. van Etten, surgery, UMCG B. Glimelius, radiation-medical …",Ulrika Palenius,1
,,,,,Ulrika Palenius,1
,,,,,Ulrika Palenius,1
[BOOK][B] Genetic studies in familial non-BRCA breast cancer,https://openarchive.ki.se/xmlui/handle/10616/46087,C Wendt ,2017 ,"Family history is an important risk factor for breast cancer, the presence of breast cancer in a 
first degree relative in general nearly doubles the risk and the risk increases with the 
number of affected relatives. Pathogenic mutations in BRCA1, BRCA2 and other high- and …",Ylva Sandeder,1
,,,,,Ylva Sandeder,1
,,,,,Ylva Sandeder,1
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer,https://jamanetwork.com/journals/jama/article-abstract/2214084,"TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey… ","Jama, 2015 ","Importance Limited information about the relationship between specific mutations 
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer 
risks for carriers ofBRCA1/2. Design, Setting, and Participants Observational study of women …",Zakaria Einbeigi,10
[HTML][HTML] Identification of six new susceptibility loci for invasive epithelial ovarian cancer,https://www.nature.com/articles/ng.3185,"KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee… ","Nature …, 2015 ","Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) 
susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and 
BRCA2 mutation carriers who are at high risk of EOC. After imputation to 1000 Genomes …",Zakaria Einbeigi,10
[HTML][HTML] Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome,https://link.springer.com/article/10.1186/1471-2407-13-1,"E Shubbar, A Kovács, S Hajizadeh, TZ Parris, S Nemes… ","BMC cancer, 2013 ","Breast cancer is a potentially fatal malignancy in females despite the improvement in 
therapeutic techniques. The identification of novel molecular signatures is needed for earlier 
detection, monitoring effects of treatment, and predicting prognosis. We have previously used …",Zakaria Einbeigi,10
[HTML][HTML] Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival,https://www.sciencedirect.com/science/article/pii/S0923753419313389,"NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt… ","Annals of oncology, 2015 ","Background We and others have recently shown that tumor characteristics are altered 
throughout tumor progression. These findings emphasize the need for re-examination of tumor 
characteristics at relapse and have led to recommendations from ESMO and the Swedish …",Zakaria Einbeigi,10
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers,https://academic.oup.com/hmg/article-abstract/20/23/4732/557410,"DG Cox, J Simard, D Sinnett, Y Hamdi… ","Human molecular …, 2011 ","Mutations in the BRCA1 gene substantially increase a woman's lifetime risk of breast cancer. 
However, there is great variation in this increase in risk with several genetic and non-genetic 
modifiers identified. The BRCA1 protein plays a central role in DNA repair, a mechanism …",Zakaria Einbeigi,10
"Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer: a phase 2 randomized clinical trial",https://jamanetwork.com/journals/jamaoncology/article-abstract/2781086,"T Hatschek, T Foukakis, J Bjöhle, T Lekberg… ","JAMA …, 2021 ","Importance Trastuzumab emtansine (T-DM1) is presently approved for treatment of advanced 
breast cancer and after incomplete response to neoadjuvant therapy, but the potential of 
T-DM1 as monotherapy is so far unknown. Objective To assess pathologic complete response …",Zakaria Einbeigi,10
[HTML][HTML] Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial …,https://www.nature.com/articles/onc2011201,"A Rohlin, Y Engwall, K Fritzell, K Göransson… ","Oncogene, 2011 ","Familial adenomatous polyposis (FAP) is caused by germline mutations in the adenomatous 
polyposis coli (APC) gene. Two promoters, 1A and 1B, have been recognized in APC, and 
1B is thought to have a minor role in the regulation of the gene. We have identified a novel …",Zakaria Einbeigi,10
[HTML][HTML] Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741767/,"S Kimbung, A Kovács, A Danielsson, PO Bendahl… ","Oncotarget, 2015 ","The relevance of the intrinsic subtypes for clinical management of metastatic breast cancer 
is not comprehensively established. We aimed to evaluate the prevalence and prognostic 
significance of drifts in tumor molecular subtypes during breast cancer progression. A well-…",Zakaria Einbeigi,10
[HTML][HTML] Immune gene expression and response to chemotherapy in advanced breast cancer,https://www.nature.com/articles/bjc2017446,"T Foukakis, J Lövrot, A Matikas, I Zerdes… ","British journal of …, 2018 ","Background: Transcriptomic profiles have shown promise as predictors of response to 
neoadjuvant chemotherapy in breast cancer (BC). This study aimed to explore their predictive 
value in the advanced BC (ABC) setting. Methods: In a Phase 3 trial of first-line chemotherapy in …",Zakaria Einbeigi,10
The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation,https://www.nature.com/articles/5200704,"A Bergman, Z Einbeigi, U Olofsson, Z Taib… ","European Journal of …, 2001 ","The most recurrent BRCA1/BRCA2 mutation in Sweden is the BRCA1 mutation 3171ins5. In 
the western part of Sweden this mutation accounts for as much as 77% of identified mutations 
in these two genes. Our aim was to analyse in detail the haplotype and founder effects of …",Zakaria Einbeigi,10
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast …,https://clincancerres.aacrjournals.org/content/22/1/146.short,"S Kimbung, I Johansson, A Danielsson, S Veerla… ","Clinical cancer …, 2016 ","Purpose: The complete molecular basis of the organ-specificity of metastasis is elusive. This 
study aimed to provide an independent characterization of the transcriptional landscape of 
breast cancer metastases with the specific objective to identify liver metastasis–selective …",Zakaria Einbeigi,20
"Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX …",https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.501,"JCS Bergh, A Andersson, J Bjohle, A Bosch… ",2019 ,"501 Background: Neoadjuvant therapy produces high rates of pathological complete response 
(pCR) and is the standard of care in HER2 positive breast cancer; however, the optimal 
treatment regimen remains to be established. Methods: In this randomized phase II study …",Zakaria Einbeigi,20
A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques,https://link.springer.com/content/pdf/10.1007/s10689-004-5812-2.pdf,"A Bergman, A Flodin, Y Engwall, EL Arkblad, K Berg… ","Familial cancer, 2005 ","Dominant inheritance is presumed in 6–10% of breast and ovarian cancers. Mutations in 
BRCA1 and BRCA2 genes are the most commonly identified causative genes in such families. 
The frequency of mutation carriers with breast/ovarian cancer depends on the population …",Zakaria Einbeigi,20
[HTML][HTML] Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus,https://link.springer.com/article/10.1186/s13058-016-0718-0,"C Zeng, X Guo, J Long, KB Kuchenbaecker… ","Breast cancer …, 2016 ","Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide 
polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. We 
performed a fine-scale mapping study of a 700 kb region including 441 genotyped and more …",Zakaria Einbeigi,20
[HTML][HTML] High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer,https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-13-47,"E Shubbar, K Helou, A Kovács, S Nemes… ","BMC …, 2013 ","Previously, we performed analysis of gene expression in 46 axillary lymph node negative 
tumors and identified molecular gene signatures that resulted in different clinical outcomes. 
The aim of this study was to determine the correlation of γ-glutamyl hydrolase (GGH), fatty acid …",Zakaria Einbeigi,20
[HTML][HTML] Psychological reactions to progression of metastatic breast cancer-an interview study,https://journals.lww.com/cancernursingonline/fulltext/2009/01000/Psychological_Reactions_to_Progression_of.10.aspx,"H Svensson, Y Brandberg, Z Einbeigi, T Hatschek… ","Cancer …, 2009 ","Abstract Knowledge about how patients experience their situation at the point of disease 
progression after first-line chemotherapy is limited. It is important to investigate this area to 
better understand and support women with advanced-stage disease. The study explored …",Zakaria Einbeigi,20
[HTML][HTML] Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018,https://link.springer.com/article/10.1007/s10549-020-05822-z,"J Nyqvist, TZ Parris, K Helou, EK Sarenmalm… ","Breast Cancer Research …, 2020 ","Purpose Multiple primary malignancies (MPMs) caused by breast cancer treatment are well 
described, but only few studies to date describe which other previous primary malignancies (OPPMs) 
occur before breast cancer. The purpose of the present study was to evaluate the …",Zakaria Einbeigi,20
"Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer",https://link.springer.com/content/pdf/10.1007/s12032-011-9844-9.pdf,"H Svensson, T Hatschek, H Johansson, Z Einbeigi… ","Medical Oncology, 2012 ","The purpose of this study was to, on an exploratory basis, investigate the role of health-related 
quality of life (HRQoL) at randomization as an independent prognostic factor for response to 
treatment, progression-free survival (PFS), and survival. In the TEX trial, 287 patients with …",Zakaria Einbeigi,20
[PDF][PDF] Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a …,https://link.springer.com/content/pdf/10.1007/s10549-016-4018-2.pdf,"Y Hamdi, P Soucy, KB Kuchenbaeker… ","Breast cancer research …, 2017 ","Purpose Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in 
part, explain the underlying phenotypic variation associated with many complex diseases. To 
investigate whether common variants associated with DAE were involved in breast cancer …",Zakaria Einbeigi,20
Metachronous and synchronous occurrence of 5 primary malignancies in a female patient between 1997 and 2013: a case report with germline and somatic genetic …,https://www.karger.com/Article/Abstract/484403,"J Nyqvist, F Persson, TZ Parris, K Helou… ","Case reports in …, 2017 ","The number of patients with multiple primary malignancies has been increasing steadily in 
recent years. In the present study, we describe a unique case of an 81-year-old woman with 
5 metachronous and synchronous primary malignant neoplasms. The patient was first …",Zakaria Einbeigi,20
[HTML][HTML] A search for modifying genetic factors in CHEK2: c. 1100delC breast cancer patients,https://www.nature.com/articles/s41598-021-93926-x,"C Wendt, TA Muranen, L Mielikäinen… ","Scientific Reports, 2021 ","The risk of breast cancer associated with CHEK2: c. 1100delC is 2–threefold but higher in 
carriers with a family history of breast cancer than without, suggesting that other genetic loci in 
combination with CHEK2: c. 1100delC confer an increased risk in a polygenic model. Part of …",Zakaria Einbeigi,30
Breast cancer survival trends in different stages and age groups–a population-based study 1989–2013,https://www.tandfonline.com/doi/abs/10.1080/0284186X.2018.1532601,"AE Nordenskjöld, H Fohlin, LG Arnesson… ","Acta …, 2019 ","Background: During the recent decades, breast cancer survival has gradually improved but there 
is limited knowledge on the improvement in population-based studies of patients diagnosed 
with different stages of the disease and in different age groups. Patients and methods: …",Zakaria Einbeigi,30
PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients,https://clincancerres.aacrjournals.org/content/23/23/7225.abstract,"NP Tobin, A Lundberg, LS Lindström, JC Harrell… ","Clinical Cancer …, 2017 ","Purpose: Transcriptional pathway activity and the molecular subtypes of breast cancer 
metastases have been shown to significantly influence patient postrelapse survival. Here, we 
further determine the relevance of clinically employed gene signatures in the advanced breast …",Zakaria Einbeigi,30
Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden,https://link.springer.com/content/pdf/10.1007/s10689-006-9101-0.pdf,"Z Einbeigi, A Bergman, JM Meis-Kindblom, A Flodin… ","Familial cancer, 2007 ","Aim: This study aimed to analyze whether the occurrence of both breast and ovarian cancer in 
a woman serves as a marker for BRCA gene mutations. Material and methods: This 
population-based study included 256 women in western Sweden who developed both invasive …",Zakaria Einbeigi,30
[HTML][HTML] Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine),https://link.springer.com/article/10.1007/s10549-010-1084-8,"H Svensson, Z Einbeigi, H Johansson… ","Breast cancer research …, 2010 ","The aim of this study was to compare the effects on health-related quality of life (HRQOL) of 
two treatment regimens in the TEX trial during 9 month from random assignment, with 
emphasis on the 2- and 9-months assessments. A total of 287 patients were randomized to …",Zakaria Einbeigi,30
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts,https://www.mdpi.com/1097552,"N Oparina, MC Erlandsson, AF Beding, T Parris… ","Cancers, 2021 ","Breast cancer (BC) histological and molecular classifications significantly improved the 
treatment strategy and prognosis. Inhibitor of apoptosis BIRC5/survivin is often overexpressed 
in cancers, however, indications of its importance in BC are inconsistent. We integrate BIRC5 …",Zakaria Einbeigi,30
[HTML][HTML] The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004 …,https://link.springer.com/article/10.1186/s12885-019-5373-2,"S De Lara, J Nyqvist, EW Rönnerman, K Helou… ","BMC cancer, 2019 ","Current prognostic markers cannot adequately predict the clinical outcome of breast cancer 
patients. Therefore, additional biomarkers need to be included in routine immune panels. 
FOXA1 was a significant predictor of favorable outcome in primary breast cancer, while Nestin …",Zakaria Einbeigi,30
[HTML][HTML] A hypothesis-generating search for new genetic breast cancer syndromes-a national study in 803 Swedish families,https://hccpjournal.biomedcentral.com/articles/10.1186/1897-4287-5-1-17,"A von Wachenfeldt, A Lindblom… ","Hereditary …, 2007 ","Among Swedish families with an inherited predisposition for breast cancer, less than one 
third segregate mutations in genes known to be associated with an increased risk of breast 
cancer in combination with other types of tumours. In a search for new putative familial breast …",Zakaria Einbeigi,30
Genetic alterations associated with multiple primary malignancies,https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.3975,"J Nyqvist, A Kovács, Z Einbeigi, P Karlsson… ","Cancer …, 2021 ","Breast cancer (BC) patients are frequently at risk of developing other malignancies following 
treatment. Although studies have been conducted to elucidate the etiology of multiple primary 
malignancies (MPM) after a BC diagnosis, few studies have investigated other previously …",Zakaria Einbeigi,30
[HTML][HTML] The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicity,https://www.spandidos-publications.com/10.3892/ol_00000028,"A ÖFvERHoLM, Z Einbeigi… ","Oncology …, 2010 ","Paclitaxel is a frequently used anticancer drug with considerable inter-individual variability in 
terms of drug efficiency and toxicity. The reasons for this variability have not been fully explained. 
The purpose of this study was to evaluate the possible relationship between paclitaxel-…",Zakaria Einbeigi,30
